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 Bacteriocins are narrow-spectrum antibiotics produced in nearly all 
lineages of bacteria, meaning that these antimicrobials target closely related 
individuals. The bacteriocins of Pseudomonas aeruginosa, called pyocins, are 
highly prevalent and diverse in populations of this species. Laboratory studies 
have shown that pyocins can function to mediate the outcome of interactions, 
often allowing for the coexistence of multiple strains, as no one pyocin genotype 
is competitively superior.  Although this has been demonstrated under laboratory 
conditions, the function of pyocins in natural settings and the ecological, 
evolutionary, and genetic mechanisms underlying pyocin diversity remains 
unclear. As such, for my dissertation, I conducted research that investigated the 
driving forces underlying diversity in pyocin phenotype and genotype in free-living 
isolates of P. aeruginosa. 
In Chapter II, I collected P. aeruginosa isolates from spatially structured 
household bathroom and kitchen sink drains to examine relationships among 
pyocin phenotype with spatial structure, environment of isolation, resource 
competition, and phylogenetic distance. I found isolates from different houses
v 
 and different drain types to vary in pyocin-mediated inhibition, suggesting that 
dispersal limitations and environmental conditions help shape pyocin diversity. I 
also found that pyocin-mediated inhibition was most likely to occur between 
isolates that were intermediately phylogenetically related, but inhibition was not 
driven by resource competition.  
 In Chapter III, I searched genome sequences of the isolates in my 
collection for pyocin genes to investigate the relationships between pyocin 
genotype and spatial structure, environment of isolation, and pyocin phenotype. I 
found isolates collected from bathroom sink drains to encode more pyocin genes 
than those collected from kitchen sink isolates, and isolates from different houses 
varied primarily with respect to pyocin immunity genes. These findings indicate 
that environment of isolation and, to a lesser extent, spatial structure contribute 
to differences in pyocin gene content. I found that while immunity genes and 
particular killing genes partially contribute to the outcome of inhibitory 
interactions, pyocin-mediated inhibition is a complex process likely driven by 
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Biogeography is a discipline that seeks to characterize the patterns of 
biodiversity over space and time as well as gain an understanding of the 
processes underlying these observed patterns. Biogeography has long been 
studied in macro-organisms, such as plants and animals, and it has been well-
documented that these systems exhibit particular biogeographic patterns [1, 2]. 
Conversely, the patterns that might arise in bacterial biogeography have 
historically been unexplored. However, advancements in sequencing 
technologies now allow for deeper investigations into bacterial diversity, and this 
has increased the capability to investigate biogeographic patterns in these 
organisms [3, 4].  
Martiny et al. [5] defined four hypotheses that seek to understand the 
processes influencing bacterial biogeographic patterns. The first, a null 
hypothesis, is that these organisms do not exhibit biogeographic patterns, 
meaning they are randomly distributed in space. The second hypothesis is often 
referred to as the Baas-Becking Hypothesis: “Everything is everywhere – the 
environment selects” [6], suggesting that the distribution of bacteria reflects only 
current abiotic and biotic conditions in the environment. A third hypothesis 
proposes that bacterial patterns are influenced by historical
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 conditions such as dispersal limitations and past environmental conditions. The 
last hypothesis combines the second and third hypotheses by arguing that 
patterns of diversity in bacteria reflect both current conditions and past events 
[5].   
Empirical studies have widely demonstrated that free-living bacterial 
species display non-random biogeographic patterns in nature [7-10], which 
allows us to reject the null hypothesis. Overall, it appears that both current 
environmental conditions and historical processes affect bacterial composition, 
suggesting that the last hypothesis proposed by Martiney et al. [5] may most 
accurately reflect the biological underpinnings of bacterial biogeography. Studies 
in bacterial populations have examined relationships between diversity and 
geographic distance, which provides insight into the historical processes 
underlying observed patterns of diversity, such as dispersal limitations as well as 
previous selection and drift. Large-scale intercontinental studies in 
Synechococcus [11] and Sulfolobus [7] assemblages have revealed strong 
effects of geographic distance on bacterial and archaeal composition, 
respectively. Furthermore, studies done at smaller spatial scales in 
Pseudomonas fluorescens [12] and among species in the Xenorhabdus genus 
[13] have revealed genotypic and phenotypic differences among geographically 
isolated bacteria. Some studies, however, have not identified this pattern [14], 
suggesting that the detection of such a relationship varies among studies, taxa, 
methodology, and perhaps, to an extent, the scale of the study.  
Additionally, studies in bacterioplankton, microbial communities in aquatic 
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environments, and soil bacterial communities in rhizospheres have found that 
contemporary environmental conditions play a significant role in influencing 
bacterial composition [15, 16], which supports the Baas-Becking Hypothesis. 
While less common, some studies examine the effects of both geographic 
distance and environmental conditions on bacterial composition and have found 
evidence signifying that both factors play an important role in shaping patterns of 
distribution in these organisms [8, 10, 17]. Taken together, these findings indicate 
that historical events and current conditions can contribute to patterns of bacterial 
diversity, but the degree of this influence may be dependent upon the scale of 
the study as well as the study system. 
Notably, at least some dispersal limitation is required to detect a 
relationship between geographic distance and diversity because differentiation 
due to past events would be countered by homogenizing selection imposed 
under high rates of dispersal [18]. The detection of such a relationship with 
geographic distance can also be impacted by a bacterial taxon’s ability to 
colonize a new location [5]. For example, some taxa are more tolerant to 
stressful conditions and, therefore, may be able to more easily colonize new 
locations than other taxa that are more fastidious. A study done using species in 
the Bacillus genus showed that this spore-forming organism has high rates of 
migration, which minimizes the influence of geographic distance on these 
populations [19]. Additional factors that may play an important role in the 
colonization rate of a bacterium are interactions with residents of a new location, 
including competitive and synergistic interactions, and population density, as a 
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higher population density would allow for colonization more easily.  The type of 
environment will also play a role in a bacterium’s dispersal capabilities; certain 
habitats, such as those in aquatic settings, will allow for higher rates of dispersal 
than those in terrestrial environments [5]. 
Due to the small number of studies addressing the effects of both 
geographic distance and current environmental conditions, more research is 
needed across different taxa to identify the specific mechanisms underlying 
bacterial biogeography. In this dissertation, by using strains of Pseudomonas 
aeruginosa collected from spatially structured kitchen and bathroom sink drains 
across different houses, I explored the extent to which these previously 
mentioned underlying mechanisms contributed to patterns of diversity observed 
in my strain collection. 
Bacterial Competition 
The effects of biotic factors, such as the composition and abundance of 
other microorganisms, are often neglected in studies of bacterial biogeography. 
However, when examined, bacterial composition often correlates to measured 
biotic variables, suggesting that processes due to biotic variables may play a role 
in shaping patterns of bacterial biogeography [20]. 
One biotic variable contributing to patterns of bacterial diversity is 
competition over shared resources. Like macro-organisms, bacteria compete 
over shared, limiting resources such as carbon, nitrogen, and metals [21]. 
Resource competition can be placed into two categories: scramble (passive) and 
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interference (contest) competition [22]. Scramble competition among 
microorganisms occurs when organisms compete indirectly through rapid growth 
or through the secretion of extracellular molecules used to obtain nutrients [20]. 
For example, the bacterial species Escherichia coli can shift its metabolism in the 
presence of oxygen, which allows it to grow more quickly and take up nutrients 
faster than its competitors [23].  
Another form of scramble competition is mediated through the production 
and release of extracellular molecules such as siderophores, which are iron-
scavenging compounds that can obtain free iron in the environment for use by 
the producing cell. While siderophores could help to mediate competitive 
interactions due to differences in iron-binding affinities of different siderophore 
molecules [24], production of these iron-binding molecules may also be 
considered a cooperative behavior because, when they are produced, the bound 
iron is considered a “public good” and can be taken up by other bacterial cells in 
some cases [25]. Consequently, this can sometimes lead to “cheating,” a 
phenomenon in which cells can exploit a resource produced by a competitor 
without expending the energy to manufacture the product themselves. In other 
words, cells may lose the ability to produce and release siderophores but retain 
the ability to take up the iron bound to them [26-29]. Another example of 
cooperation and consequential cheating in P. aeruginosa occurs during a 
process called quorum sensing (QS) that allows bacterial cells to communicate 
through the release of signal molecules. The observance of “cheaters” in this 
process has been identified when cells benefit from this process but do not 
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produce the QS molecules themselves [30, 31]. 
Interference competition occurs when organisms compete by directly 
damaging one another. One such type of interference competition in bacteria is 
contact-dependent and mediated through the Type VI secretion system (T6SS), 
in which a needle-like apparatus is used to inject toxins directly into a target cell 
[32]. Another mechanism of interference competition is the secretion of 
antimicrobial compounds, which is widespread in all lineages of bacteria [5, 20] 
Some researchers have proposed that, instead of modulating competitive 
interactions, sub-inhibitory levels of antimicrobials could function as signaling 
molecules for cell-to-cell communication purposes [33]; however, numerous 
empirical studies in laboratory settings have shown that the production of these 
molecules does, in fact, play a significant role in mediating the outcomes of 
competitive interactions [34].  
Furthermore, the killing range of a cell that is secreting antibiotics (the 
“producing cell”) can often be correlated to its habitat and lifestyle, further 
providing evidence of these compounds' role in natural settings. As such, a 
generalist species that inhabits a diverse microbial habitat may benefit from the 
production of broad-spectrum antimicrobials that are effective against a wide 
range of microorganisms due to the variety of competitors it is likely to encounter. 
For example, species in the Streptomyces genus are commonly found in highly 
diverse environments such as in soils, and organisms in this bacterial genus 
carry genes for a wide array of antimicrobial compounds [35]. On the other hand, 
a specialist species with specific habitat requirements may be more likely to 
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produce narrow-spectrum antibiotics that are effective against a smaller, more 
targeted group of microorganisms as it is not likely to encounter a diverse group 
of competitors [36]. Therefore, the production of antimicrobials plays an important 
role in mediating competition both within and between species. 
The long-term evolutionary consequence of bacterial competition is a 
reduction in diversity at a local scale – the scale at which cells directly interact 
and impact one another. This is due to competitive exclusion, a phenomenon in 
which one organism outcompetes the other and drives it to extinction [37]. These 
interactions may also drive organisms to specialize on different resources and 
occupy new niches (niche partitioning) or, in the presence of spatial structure, 
microorganisms may have the capacity to coexist [36]. This dissertation explores 
the patterns of diversity in narrow-spectrum antibiotics, called bacteriocins, 
observed at different spatial scales and investigates the potential evolutionary 
remnants of competition mediated through these compounds' production. 
Hamilton’s Theory of Inclusive Fitness 
Social behaviors such as altruism and spite are another mechanism 
underlying bacterial diversity. Darwin’s theory of natural selection predicts that 
traits associated with greater reproductive success will be acted upon by 
selection and accumulate in natural populations [38]. Consequently, selection for 
social behaviors such as selfishness and mutualism are well supported by 
Darwin’s ideas as these interactions will lead to an increase in reproductive 
success for the actor, who is the individual initiating the behavior, or both the 
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actor and the recipient, who is the individual targeted by the behavior [39]. Less 
clear, however, are the reasons behind other social behaviors, such as altruism 
and spite, that may decrease the reproductive output of the individual initiating 
the behavior [40, 41]. The reasoning underlying these behaviors is difficult to 
understand as the actor will incur a fitness cost when performing altruistic or 
spiteful actions to provide a benefit, in the case of altruism, or to harm, in the 
case of spite, the individual on the receiving end of the behavior.  
In the 1960s, Hamilton noted that behaviors such as altruism and spite 
could not be explained by Darwin’s theories alone; however, they could be 
supported by the principle of inclusive fitness [40, 41]. Hamilton developed a 
theory that defined inclusive fitness as the sum of direct fitness, which is gained 
through producing offspring, and indirect fitness, which is obtained through 
interactions with close kin or individuals of common descent. He argued that 
although altruism and spite decrease an individual’s direct fitness, these 
behaviors may increase indirect fitness, thereby maximizing inclusive fitness [40, 
41]. 
Altruism, the more studied and well understood of these social behaviors, 
is predicted to occur if the indirect fitness benefits are aimed toward individuals 
with high genetic relatedness to the actor; this action will increase the frequency 
of the genes shared by the individuals participating in this interaction [40, 41]. 
This behavior, mathematically modeled by Hamilton, will be favored by selection 
when rb-c>0, where r is genetic relatedness between the actor and recipient, b is 
the fitness benefit to the recipient, and c is fitness cost to the actor [40, 41].  
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Altruism is clearly observed in highly eusocial insects, such as ants and bees, in 
which sterile workers give up the opportunity for independent reproduction to 
help individuals with high genetic relatedness, or their kin [42]. As a result, these 
interactions are often referred to as “kin selection” [43]. Another well-studied 
example of altruism exists in a group of social amoebae, often referred to as 
slime molds, particularly within the species Dictyostelium discoideum [44]. Under 
normal conditions, D. discoideum exists in a unicellular form; however, under 
conditions of low nutrients, these cells come together to form a multicellular slug. 
This slug transforms into a fruiting body through the differentiation of cells into a 
cluster of spores or into a long, rigid stalk, which supports the cluster of spores. 
The cells that make up the stalk are nonviable, and about 20% of these cells will 
die to support the reproduction of cells that have differentiated into spores in 
what appears to be a classic example of altruistic behavior [44].   
Spite – the Dark Side of Altruism 
Spite, the darker side of altruism, refers to behaviors that decrease the 
reproductive output of both the actor and the recipient [45]. Because spite is less 
understood and more rarely observed than altruism, it has been historically 
confused with selfishness, which harms a recipient but leads to a direct fitness 
increase for the actor. Selfish behaviors differ from spite, as truly spiteful 
behaviors must be costly in terms of fitness to both the actor and the recipient 
[39]. Spiteful behaviors can be explained by Hamilton’s theory of inclusive fitness 
because, like altruism, spite maximizes inclusive fitness through a decrease in 
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direct fitness with a subsequent increase in indirect fitness [40, 41]. Like altruism, 
spite will be favored when rb-c>0; with spiteful behaviors, however, r is a 
negative genetic relatedness, meaning that the recipient is less related to the 
actor than the average member of the population. Furthermore, b is a negative 
benefit, meaning that the action has a negative impact on the recipient, and c is 
positive, meaning that the action is also costly to the actor. Therefore, a spiteful 
behavior will be favored if the negative genetic relatedness and negative impact 
on the recipient can outweigh the cost to the actor [40, 41, 45]. Contrasting with 
this theory is Wilsonian spite, which predicts that, in order for a spiteful behavior 
to occur, the indirect beneficiary of the spiteful behavior must be more genetically 
related to the actor than the individual on the direct receiving end of the behavior 
[46, 47]. Spite is rarely observed in nature as the particular population conditions 
that favor harming non-relatives to effectively help relatives are quite difficult to 
obtain [39, 45]; however, one clear example of a spiteful behavior is the bacterial 
production of anticompetitor toxins, such as bacteriocins [45].  
Bacteriocins – Spiteful, Narrow-spectrum Antibiotics 
Bacteriocins, a diverse family of antimicrobial toxins found in upwards of 
99% of Gram-negative and Gram-positive bacteria, are often cited as a classic 
example of spite, as these antibiotics result in a fitness cost to both the actor and 
the recipient [45, 48, 49]. As well as being costly to produce, bacteriocins are 
also typically released through lysis in Gram-negative bacteria, which kills the cell 
producing and releasing the bacteriocin [48]. Moreover, laboratory studies have 
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demonstrated that, when grown alone, bacteriocin producers have a slower 
growth rate than non-producers, which shows the cost of carrying these toxins on 
reproductive fitness [48]. Unlike traditional antibiotics, bacteriocins are 
conventionally believed to have a relatively narrow killing spectrum, meaning that 
the capacity for killing by a bacteriocin producer is restricted to members of the 
same species or closely related species. This specificity results from the 
bacteriocin’s requirement to bind to a particular receptor on the surface of a 
target cell in order for killing to occur [48]. However, recent research has shown 
that this general assumption does not hold for all bacteriocin-producing 
organisms [50-52].  For example, a study in enteric bacteria, such as E. coli and 
members of the Klebsiella genus, found that many of the strains used in this 
study exhibited a surprisingly high level of interspecific inhibition with many 
strains able to inhibit members of different taxa [52]. Additionally, the bacteriocins 
of Pseudomonas aeruginosa, called pyocins, have the potential to be effective 
against other species in the Pseudomonas genus and species in the 
Burkholderia genus [50,51]. However, these studies confirm that, to an extent, 
traditional assumptions of the narrow killing spectrum hold true as bacteriocin-
mediated inhibition has been found to occur more frequently within a species 
compared to interactions observed between different species. 
Laboratory studies have demonstrated that, under certain conditions, the 
bacteriocins of E. coli, called colicins, have the ability to play important roles in 
maintaining intraspecies diversity through the creation of non-transitive networks, 
sometimes referred to as rock-paper-scissors networks, in which multiple strains 
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can coexist due to different colicin genotypes and mechanisms of resistance [53]. 
For example, it is possible to have a strain capable of producing a bacteriocin, 
which may give it a competitive advantage over a strain that is sensitive to the 
bacteriocin. However, because these toxins are costly to carry and release, the 
producer is at a disadvantage because it has to pay this cost while the sensitive 
strain does not. Additionally, there could also exist a non-producing, resistant 
strain that cannot be killed by the producer but must pay the cost of resistance, 
usually through a mutation in the cell surface receptor, which is not paid by the 
sensitive strain. Therefore, a non-transitive rock-paper-scissors network can be 
maintained in which no one strain can outcompete the other [53]. However, the 
maintenance of such a network is dependent upon rates of dispersal and will be 
preserved only under conditions in which dispersal is limited, and therefore 
interactions occur locally, such as that of a static agar plate [34, 53, 54]. When 
rates of dispersal are high and interactions are occurring globally, such as within 
a shaking flask, the resistant strain can competitively exclude both the producer 
and sensitive strain as a result of homogenizing selection [34,53]. 
Bacteriocin diversity in nature has been explored in previous studies [12, 
14, 51, 55-58]; however, it remains unclear if this diversity is a result of historical 
or contemporary processes, or if these antibiotics are playing an active, 
functional role in the maintenance of overall microbial diversity, thereby 
contributing to the structure of natural microbial assemblages. Furthermore, it is 
unclear if bacteriocin production is, in fact, a truly spiteful behavior and if the 
proposed genetic mechanisms driving such a behavior can be detected in natural 
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microbial populations. This dissertation addresses the relationship between 
genetic relatedness and spiteful interactions mediated through the production of 
bacteriocins in P. aeruginosa. This was done by observing bacteriocin-mediated 
interactions among the P. aeruginosa isolates in my collection and measuring the 
phylogenetic distance between them. Specifically, this work seeks to elucidate 
the mechanisms underlying bacteriocin diversity by investigating patterns in 
genotype and phenotype among environmental isolates of P. aeruginosa.  
Pseudomonas aeruginosa – a Versatile, Opportunistic Pathogen 
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen 
perhaps most widely known and studied for causing chronic infections in 
individuals with Cystic Fibrosis (CF), an autosomal recessive disorder caused by 
a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) 
[59, 60]. This mutation leads to a buildup of thick mucus in the lungs, which 
allows for sustained bacterial colonization. P. aeruginosa is one of the leading 
causes of morbidity and mortality in these individuals [60]; once this organism 
colonizes the lungs of an individual with CF, it is nearly impossible to eradicate 
[60]. This species is also responsible for a wide variety of infections including 
those in wounds, burns, and other nosocomial infections [61].  
Pseudomonas aeruginosa PAO1, the most commonly studied and well-
characterized laboratory strain of P. aeruginosa, has a relatively large genome 
size comprised of ~6.3 million base pairs with a GC content of ~66.6% and 5,570 
predicted open reading frames (ORFs) [62]. For comparison, E. coli has a 
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genome size of 4.6 million base pairs with a GC content of 50.8% and 4,288 
predicted open reading frames [63]. The large genome size of P. aeruginosa is 
thought to be due to increased genetic complexity and functional diversity. 
Compared to other well-studied bacterial species such as E. coli, Mycobacterium 
tuberculosis, and Bacillus subtilis, P. aeruginosa has more distinct paralogous 
groups of genes, or genes that have resulted from gene duplication but are 
functionally distinct from one another [62]. Furthermore, P. aeruginosa PAO1 
was found to have a large number of transcriptional regulators and environmental 
sensors as well as diverse metabolic pathways and enzymes related to oxidative 
metabolism. Taken together, these components indicate that the genetic intricacy 
and regulatory flexibility, as well as variable metabolic capabilities, allow P. 
aeruginosa to persist in a wide variety of environmental conditions [62].  
P. aeruginosa in the Built Environment 
P. aeruginosa has historically been characterized as an organism with a 
broad fundamental niche, meaning that it has the ability to persist in a wide array 
of environmental conditions [62]. As such, this species has long been perceived 
as a global or ubiquitous organism. This has been an accepted hypothesis 
because P. aeruginosa is known for its wide metabolic capabilities and has also 
been isolated from a diverse array of environments including soils, water, and 
marine environments. Furthermore, as this is a particularly significant pathogen 
for individuals with CF, it has been of interest to determine the initial source of P. 
aeruginosa infection in these individuals. While patient-to-patient transmission of 
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P. aeruginosa has been well documented [64-66], other potential sites harboring 
this species remain unclear. It is possible that certain environmental reservoirs of 
P. aeruginosa may also serve as a source of infection for these individuals.  
To determine potential sources of initial infection, studies have examined 
P. aeruginosa distribution within the built environment, with a particular focus on 
hospital settings. In these environments, P. aeruginosa has been isolated from 
places such as sinks, drains, and water [67-70]. Additionally, previous studies 
have focused on identifying potential sources of P. aeruginosa within 
households, as this setting may also harbor P. aeruginosa [71-74]. Although P. 
aeruginosa is often referred to as ubiquitous, studies that have sampled the 
households of either individuals with CF or the households of individuals without 
CF, have found that P. aeruginosa is not always recovered, which contrasts with 
the perception that this is a global organism with a broad fundamental niche. In 
fact, Remold et al. [74] found that P. aeruginosa was never recovered from 
indoor or outdoor soils and was rarely recovered from tap water samples, despite 
previous studies reporting isolating P. aeruginosa from these sources [75-77]. 
Another study, however, supports the findings of Remold et al. [74] through the 
observation that P. aeruginosa occurrence is rare in agricultural soil samples 
[77].  
When P. aeruginosa is recovered from a household, it appears that this 
organism displays a high specificity in these environments, as it is most 
frequently recovered from the drains of kitchen sinks, bathroom sinks, showers, 
or toilets. Furthermore, some studies report that P. aeruginosa shows specificity 
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to sub-categories of sampling locations such as types of drains. For example, 
Remold et al. [74] found P. aeruginosa to be isolated significantly more often 
from bathroom sink drains than kitchen sink drains. However, other studies, 
including another study done by Remold et al. [73] have not identified this 
pattern.  In fact, Regnath et al. [71] recovered P. aeruginosa from 35% of kitchen 
sink drains and 34% of bathroom sink drains. The potential differences in 
recovery rates from bathroom and kitchen sink drains could be due to a variety of 
biotic and abiotic factors or from sampling bias. Regnath et al. [71] proposed that 
sinks used more frequently may be less likely to harbor P. aeruginosa because 
the increase in water flow may displace bacterial cells. These sampling studies 
indicate that, while P. aeruginosa is described as having the ability to persist in a 
wide array of environmental conditions, its realized niche, or the distribution that 
this organism actually exhibits in nature, appears to be much more constrained 
than its fundamental niche.  
This dissertation continues the work in investigating the distribution of P. 
aeruginosa in households; however, we instead focus on sampling only 
bathroom and kitchen sink drains, as we know these are the locations most likely 
to harbor P. aeruginosa and this allowed us to investigate potential differences in 
recovery from different types of sink drains. 
Pyocins – the Bacteriocins of P. aeruginosa 
The bacteriocins of P. aeruginosa, called pyocins in this species, are one 
of the more well-characterized bacteriocin systems. Pyocins differ from 
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bacteriocins produced in other species in that they are both highly abundant in P. 
aeruginosa populations as well as incredibly diverse. The pyocins of P. 
aeruginosa display variability in genetic structure, mode of action, and killing 
range. Furthermore, unlike the bacteriocins of other species, which are located 
on plasmids, pyocins are chromosomally encoded [78, 79]. Pyocins have been 
placed in three categories: S, R, and F. The S-type pyocins are soluble and 
share homology to the colicins of E. coli, while the R- and F- type pyocins are 
multiprotein molecules that are similar to bacteriophage [80]. There are multiple 
subtypes within each of these categories and strains have the ability to carry 
unique combinations of each type [80]. The S, R, and F pyocins are discussed in 
more detail later in this chapter. 
Regulation of Pyocin Expression 
Due to the costly nature of pyocin production and release [80], pyocin and 
other associated genes are not constitutively expressed, meaning that these 
proteins are not always present in the cell. Instead, these genes are regulated 
through the SOS response, which occurs when bacteria respond to DNA damage 
[80-82]. While the SOS response in P. aeruginosa is more complex than that of 
other species like E. coli, the mechanism of pyocin expression as it relates to this 
response is similar in that it is also coordinated through the production of a 
protein called RecA (Fig. 1). Under conditions in which DNA damage occurs, a 
nucleoprotein called RecA will mediate the autocleavage of a protein called PrtR. 
Under normal conditions, PrtR acts as a repressor for prtN, a gene that encodes 
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for an activator of pyocin expression. However, under stressful conditions, PrtR is 
cleaved, which derepresses prtN and allows for synthesis of its protein. PrtN 
binds to particular sequences called P-boxes in the promotor regions of S, R, and 
F-type pyocins [81]. This process leads to the expression of all pyocin genes as 
well as a presumptive group of lysis genes that allow for the release of the 
pyocins from the cell [83]. Both prtN and prtR are conserved across strains of P. 
aeruginosa, which suggests that this regulatory system for pyocin expression is 
conserved throughout this species [81, 82].  However, It is notable, that while P-
boxes have been identified upstream of the majority of pyocins, an S-type pyocin 
called S5 does not have an identifiable P-box sequence, suggesting that this 
pyocin may have a different regulatory pathway than that of other pyocins [84]. 
Figure 1. Regulation of pyocin gene expression under normal conditions (A) and 
under conditions in which pyocin expression is induced (B) through stress or 
DNA damage.  




















 The S-type pyocins contain many subtypes, S1-S6 as well as AP41, that 
have been empirically confirmed to demonstrate bactericidal activity [80]. 
Additionally, there are presumptive subtypes S7-S12, which have been predicted 
through P. aeruginosa genomic analysis [85]. The subtypes of S-type pyocins 
exhibit diversity in genetic structure, mode of action, and receptor specificity.  
The genetic determinants of S-type pyocins share homology to the colicins 
of E. coli [80]. Colicin gene clusters have three components: a toxin gene 
responsible for killing activity, an immunity gene providing protection for the 
producer cell, and a lysis gene that enables a producing cell to release the toxin 
(Fig. 2) [48, 86]. The immunity gene provides protection for the producer cell 
because when this protein is synthesized, it will bind to and inactivate the toxin 
protein [48]. While the majority of S-type pyocins share this genetic organization 
[79, 87], previous studies have shown that some strains will lack a toxin gene but 
carry the corresponding immunity gene, which, in these instances, is referred to 
as an “orphan” gene [55, 88]. Additionally, S-type pyocins do not appear to have 
an identifiable lysis gene expressed alongside the toxin and immunity genes (Fig. 
2) [80]. It has been proposed, however, by Nakayama et al. [83] that S-type
pyocins may be released from a producer cell using a lysis cassette that is 
encoded in the R -and F-type pyocin gene cluster, which is discussed later in this 
chapter. 
All identified S-type pyocin toxin and immunity genes are organized in 
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operons composed of two open reading frames (ORFs), which code for both of 
these genes [79, 80, 87]. In studies on the molecular structures of S1 and S2 
pyocins, the two ORFs for both pyocin types were found in close proximity; in 
fact, the stop codon of the ORF encoding the toxin gene is separated by the start 
codon for the ORF encoding the immunity gene by a single nucleotide and the 
presumptive ribosome binding site for the immunity gene is located within the 
region encoding the terminal portion of the toxin gene. This operon organization 
suggests that, in pyocins S1 and S2, the toxin and immunity genes are translated 
together because this structure allows for continuous contact of the ribosome 
with the mRNA during translation [79]. Despite this operon organization, 
however, one study has shown that immunity proteins may be expressed singly, 
particularly under non-stressful conditions, perhaps due to regulation through 
small non-coding RNAs [89].  
Figure 2. General genetic structure of a colicin in E. coli (A) and S-type pyocin in 






S-type pyocins have a diverse array of modes of action to kill their 
sensitive competitors. Pyocins S1, S2, S3 and AP41 kill their sensitive 
competitors via DNase activity [79, 80, 90, 91]. In addition to DNase activity, it 
has been proposed that pyocin S2 can target sensitive competitors through the 
inhibition of phospholipid synthesis, although the mechanism underlying this 
inhibition is not well understood [92]. Additionally, pyocin AP41 has been shown 
to induce expression of R- and F-type pyocins as well as bacteriophage in a 
sensitive target cell [87]. Pyocin S4 is presumed to kill via tRNase activity, S6 has 
rRNase activity, and the mode of action for S5 is pore formation, which leads to 
membrane damage and leakage of cellular contents [80, 93]. 
  In order to kill a sensitive competitor, S-type pyocins must bind to specific 
cell surface receptors and subsequently be translocated into a target cell [80]. 
Subtypes vary in their receptor specificity, which, in addition to the presence of 
immunity genes, could also account for variability in killing spectra among 
different S-type pyocins. Pyocins S1, S2, S3 and S4 are taken into target cells 
via outer membrane ferripyoverdine receptors, which, under iron-limited 
conditions, are used in the uptake of siderophores. S2 and S4 [94] share the 
same receptor, siderophore ferripyoverdine receptor FvdAI, while S3 uses FvdAII 
[95] and S5 uses the FetA ferripyochelin receptor [93]. Consequently, these 
pyocins are better absorbed by sensitive cells under iron-limited conditions, due 
to an increase in the number of ferripyoverdine receptors on the surface of a 
sensitive target cell [96]. Researchers have been unable to find a specific 
receptor for pyocin S6, suggesting that perhaps this pyocin type does not target a 
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particular type of ferripyoverdin receptor [89]. Similarly, the receptor for AP41 has 
not been definitively identified; it is believed to be a different receptor than those 
of pyocins S1-S4, but one in which iron is also involved [80, 95]. Once pyocins 
have bound to the appropriate receptors, they must be translocated into the 
sensitive target cell. While little is known about the mechanism of translocation 
for S-type pyocins, it has been proposed that because of the use of 
ferripyoverdine receptors in S1-S4, these pyocins may be moved into the target 
cell through a mechanism that is similar to that of the uptake of ferrisiderophore, 
which is the TonB system [97]. The mechanism by which AP41 is translocated 
has not yet been identified, but it is theorized that this pyocin may use the 
TolQRAB system, which is an uptake pathway involved in the translocation of the 
colicins of E. coli as well as certain types of bacteriophage [80, 98].   
Pyocin S3 
Pyocin S3 ws first identified in 1995 in a strain isolated in sputum from an 
individual with CF [99] and is distinguishable from other S-type pyocins [78, 80]. 
When compared to pyocins S1, S2, and AP41, S3 shares little homology with 
these subtypes regarding to the killing or immunity proteins [78, 80]. Additionally, 
the GC contents of the killing and immunity genes in pyocin S3 were determined 
to be 56.6% and 42.7%, respectively, which is lower than that of the P. 
aeruginosa genome (66.6%) [90]. In addition to the RecA-mediated regulation 
that all pyocins share, pyocin S3 had additional transcriptional regulation factors 
at play. A small non-coding RNA, PesA, which is transcribed within the 
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pathogenicity island PAPI-1, is commonly found in clinical isolates and was first 
identified in the common clinical laboratory strain PA14. PesA has been shown to 
exert positive control on S3 toxin and immunity protein expression in these 
clinical isolates, possibly by contributing to concurrent expression of these two 
proteins, though the specific mechanism underlying this process has yet to be 
elucidated [100].  
Pyocins AP41 and S8 
While many S-type pyocins share similarities in sequence composition, S-
type pyocins AP41 and S8 have a distinctive genetic structure [80, 85, 87, 101]. 
AP41 genes are unique because they are located on a transposon, which has 
been appropriately named TnAP41. This transposon, which is composed of 3229 
base pairs, is made up of two genes encoding the killing and immunity proteins 
for AP41. These two genes are located together on an operon and are flanked by 
inverted repeat sequences, which are typically found on transposons; however, 
this operon lacks the genes necessary for transposition, such as transposase 
[101]. It has also been noted that the GC content of TnAP41 is 54.1% [101] while 
the rest of the P. aeruginosa genome is 66.6% [62], which suggests that TnAP41 
is a more recently acquired genetic element. In addition to TnAP41, another 
transposon has recently been identified in the P. aeruginosa genome as a carrier 
of a novel S-type pyocin, S8 [85]. This recently described transposon, Tn6350, 
also shares homology to the Tn3 family of transposons and is comprised of eight 
ORFs. These ORFs code for an ATPase, a transposase, a resolvase, pyocin S8, 
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an immunity protein, and three hypothetical remaining proteins that have yet to 
be characterized [85].  
Talocins – R- and F-type pyocins 
In addition to the S-type pyocins, over 90% of P. aeruginosa strains 
produce at least one of two types of pyocins, the R-type pyocin or the F-type 
pyocin, with some strains carrying genes for both types of these pyocins [80, 
102]. The R- and F-type pyocins, collectively referred to as talocins, are defective 
prophages that share many physiological similarities with bacteriophage as these 
pyocins can be induced by DNA damaging agents, display antimicrobial action, 
and require cell surface receptors in a recipient cell to function [80]. The R-type 
and F-type pyocins share homology with P2 and lambda phage, respectively, 
suggesting that these pyocins are likely ancestrally derived from these 
bacteriophages [83]. Both R- and F-type pyocins lack the genes responsible for 
head synthesis and consequently resemble headless bacteriophage tails that 
have, over time, specialized in bactericidal activity.  Respectively, the R- and F-
type pyocin complexes are made up of 14 and 17 proteins, encoded in one or 
more operons in a distinct gene cluster on the P. aeruginosa chromosome (Fig. 
3) [83].
It is thought that, like the colicins of E. coli, R and F-type pyocins are also 
released outside of the cell via lysis, but genes responsible for this process have 
not yet been well-characterized [80, 83]; however, several ORFs that could 
potentially encode lytic genes for pyocin release have been identified.  The gene 
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encoded at the PA0629 locus shows some similarity to active domains of 
chitinases, a type of lytic enzyme, which indicates that a gene encoded in this 
ORF may be a lytic enzyme to facilitate the release of pyocins [83]. Additionally, 
the genes found at the PA0629, PA0630, and PA0631 loci in P. aeruginosa 
PAO1 share homologies to phage lytic genes and, more specifically, the genes at 
the PA0614 and PA0629 loci have been empirically shown to encode lytic 
enzymes in laboratory studies as cell lysis was observed when these loci were 
cloned into E. coli [83]. Consequently, it can be inferred that some, if not all of 
these ORFs, harbor lytic genes responsible for cell lysis and release of pyocins.  
Like the S-type pyocins, the talocins have multiple subtypes (R1-R5 and 
F1-F3). The subtypes of both R- and F-type pyocins are similar structurally; 
however, there is variation among the tail fiber composition of the subtypes, 
which presumably allows for differential killing range as the tail fiber composition 
is thought to account for receptor specificity [80]. The receptors for talocins are 
lipopolysaccharides (LPS), which are large molecules found in the outer 
membrane of Gram-negative bacteria [103, 104]. Laboratory studies have 
demonstrated that R-type pyocins target the outer core component of LPS; 
however, the specific LPS target for the F-type pyocin is unknown [105]. Unlike 
the S-type pyocins, the talocins do not have immunity proteins, and instead, 




Figure 3. R/F pyocin gene cluster. Regulatory genes prtR and prtN appear in 
light grey while lysis-related genes appear in black. Genes encoding for structural 
components of R-type pyocins (A) are displayed in blue and genes encoding for 
structural components of F-type pyocins (B) are displayed in purple. 
R-type pyocins 































































































































































































































































































































































































































































































inflexible and have been named for the rigidity of their structure [80]. R-type 
pyocins are composed of a hollow cylinder capable of contraction as well as a 
baseplate and six tail fibers, which are responsible for receptor binding and target 
specificity [109-111]. When the R-type pyocin binds to and makes firm contact 
with the LPS of a target cell, the pyocin complex will rapidly contract and 
penetrate the outer membrane [103, 112]. Once this process occurs, there will be 
an arrest of macromolecule synthesis in the target cell and the intracellular 
contents will be released [113]. Cell death results from pore formation and 
subsequent membrane depolarization [80, 114].  R-type pyocins are highly 
potent, and only one R pyocin molecule is required to kill a target cell [106]. 
There are five subtypes of this pyocin, R1-R5; these subtypes differ only in their 
killing range, which is mediated through differences in tail fiber composition [113]. 
The R-type genes are located between trpE and trpG on the P. aeruginosa 
chromosome. 13 ORFs (found at loci PA0616-PA0628 in P. aeruginosa PAO1) 
have been identified as being involved in R-type pyocin production. These genes 
encode for R-type pyocin protein subunits such as the baseplate, tail fibers, tail 
tube, and tail sheath [81, 83, 115]. 
F-type pyocins 
F-type pyocins were first identified in 1967 and are flexible non-contractile 
rod-like structures and resemble flexible phage tails [116, 117]. There are three 
subtypes of F-type pyocins, F1-F3, and, like those of the R-type, these subtypes 
differ only in their tail fiber composition and the resulting killing range [117]. Little 
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is known about the specifics of the killing mechanism of the F-type pyocin, but it 
is posited that this bacteriocin also kills target cells through pore formation. 
Unlike the R-type pyocins, which can kill a target cell with only one molecule, it 
has been reported that the F1 pyocins must be present as 280 molecules to kill a 
sensitive competitor [118]. The F-type pyocin gene cluster is located downstream 
of the R-type pyocin gene cluster. 17 ORFs in this region that have been 
identified as the genes potentially responsible for F-type pyocin production: 
PA0632-PA0648 in P. aeruginosa PAO1 [83]. 
Over time, the genetic determinants of pyocins have become more well-
characterized; however, few studies have examined genetic diversity with 
respect to pyocins across different strains of P. aeruginosa, particularly in free-
living isolates. Furthermore, it is unclear if pyocin genotype can be directly linked 
to phenotype. Therefore, this dissertation addresses the pyocin genetic diversity 
in our environmental P. aeruginosa collection of isolates as well as the 
relationship between pyocin genetic determinants and patterns of inhibition 
observed in our laboratory study. 
Research plan 
While patterns of pyocin diversity have been studied in laboratory, clinical, 
and environmental isolates of P. aeruginosa to varying degrees, the ecological, 
evolutionary, and genetic mechanisms underlying this diversity in natural spatially 
isolated settings requires further investigation. This dissertation attempts to 
answer the following questions in regard to patterns of diversity in pyocin 
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genotype and phenotype in household drain isolates of P. aeruginosa: 
1. What is the relationship between spatial scale and pyocin
inhibition/susceptibility? (Chapter 2)
2. What is the relationship between environment of isolation and pyocin
inhibition/susceptibility? (Chapter 2)
3. What is the relationship between resource use and pyocin
inhibition/susceptibility? (Chapter 2)
4. What is the relationship between phylogenetic distance and pyocin
inhibition/susceptibility? (Chapter 2)
5. What are the overall patterns of diversity in pyocin genotype of our
household strain collection? (Chapter 3)
6. What is the relationship between spatial isolation (house) and pyocin
genotype? (Chapter 3)
7. What is the relationship between environment of isolation (drain type) and
pyocin genotype? (Chapter 3)
8. What is the relationship between pyocin immunity genes and inhibition?
(Chapter 3)
9. What is the relationship between the combination of pyocin killing genes
and inhibition? (Chapter 3)
A central goal of biology is understanding the processes that generate and 
maintain diversity. This research works toward this goal as it elucidates the 
evolutionary, ecological, and genetic mechanisms underlying diversity in a 
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system that is characterized by a profound amount of complexity. The ecological 
and evolutionary processes investigated in this work may provide insights into 
underpinnings of diversity in other systems of study.  
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CHAPTER II 
SPATIAL STRUCTURE MAINTAINS DIVERSITY OF PYOCIN INHIBIITON IN 
HOUSEHOLD PSEUDOMONAS AERUGINOSA 
Summary 
Nearly all bacteria produce narrow-spectrum antibiotics called 
bacteriocins. Studies have shown that bacteriocins can mediate microbial 
interactions, but the mechanisms underlying patterns of inhibition are less well 
understood. We assembled a spatially structured collection of isolates 
of Pseudomonas aeruginosa from bathroom and kitchen sink drains in nine 
households. Growth inhibition of these P. aeruginosa by bacteriocins, known as 
pyocins in this species, was measured using pairwise inhibition assays. Carbon 
source usage of these isolates was measured, and genetic distance was 
estimated using multilocus sequencing. We found that as the distance between 
sites of isolation increased, there was a significantly higher probability of 
inhibition, and that pyocin inhibition and susceptibility vary greatly among isolates 
collected from different houses. We also detected support for other mechanisms 
influencing diversity: inhibition outcomes were influenced by the type of drain 
from which isolates were collected, and while we found no indication that carbon 
source utilization influences inhibition, inhibition was favored at an intermediate 
genetic distance. Overall, these results suggest that the combined effects of 
dispersal limitation among sites and competitive exclusion within them maintain 
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diversity in pyocin inhibition and susceptibility phenotypes, and that 
additional processes such as local adaptation and effects of phylogenetic 
distance could further contribute to spatial variability. 
Introduction 
A central goal of evolutionary biology is understanding the underlying 
mechanisms that generate and maintain diversity. One factor thought to promote 
diversity in microorganisms is the production of bacteriocins, which are narrow-
spectrum antimicrobials produced by nearly all species of bacteria. These toxins 
differ from traditional antibiotics in that their targets are presumably restricted to 
members of the same species or closely related species, although there is some 
diversity among the phylogenetic killing range of these toxins [51, 52, 119]. The 
bacteriocins of Pseudomonas aeruginosa, called pyocins, are unique in both their 
highly abundant production and diversity. For example, P. aeruginosa has the 
ability to produce three different types of pyocins: S, R, and F. S-type pyocins are 
similar to the bacteriocins of E. coli, called colicins, and are typically composed of 
a toxin and immunity gene. On the other hand, R and F type pyocins resemble 
phage tails and resistance is thought to be mediated through receptor 
incompatibility [80]. Furthermore, each of these classes has multiple subtypes 
and isolates have the ability to produce unique combinations of each type [55, 
78, 80]. We use inhibition assays to expose the potential pyocin-mediated 
interactions among environmental isolates of P. aeruginosa, that may or may not 
come into contact in the field. The observation of inhibition in these assays can 
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be a result of the production of any type of pyocin (S, R, and/or F) and indicates 
that processes occurring in the environment contribute to the maintenance of 
diversity in pyocin inhibition and susceptibility. 
One process believed to maintain diversity in bacteriocins is the presence 
of spatial structure in the environment, particularly when there is limited 
dispersal. We investigate the capacity to inhibit among P. aeruginosa isolates 
collected at varying levels of spatial separation: isolates from the same drain in a 
human house, from different drains from the same house, and from different 
houses in a metropolitan region. We predict a pattern of increased inhibition 
outcomes as the sites of isolation become more spatial distant, based on likely 
dispersal limitations among these drains and the large diversity of pyocins 
described among P. aeruginosa, including among household isolates [51, 55]. 
We also expect little inhibition among isolates collected within the same drain, 
due to the elimination of susceptible phenotypes by pyocin producers or the 
evolution of resistance to pyocins encountered at the within-drain level. 
Furthermore, we predict variability in inhibition across different houses due to the 
stochastic nature of dispersal among sites, combined with the fact that there are 
no universal optimal pyocin gene contents [53]. 
Another factor that can promote diversity at a global scale is local 
adaptation to different environments [74]. This study focuses on isolates from 
household bathroom and kitchen sink drains, as previous sampling studies have 
revealed that this is where P. aeruginosa is most common in the house [73, 74]. 
Previous sampling studies have shown conflicting results regarding the 
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differences in P. aeruginosa recovery between bathroom and kitchen sink drains, 
with some studies showing P. aeruginosa to be more common in bathrooms [74] 
[72] while others show no differences in recovery between drains from these 
types of rooms [71, 73]. This possible difference in recovery draws attention to 
the fact that environments may have differences such as the physical shape, 
frequency of use, and types of inputs associated with them. Such differences 
may result in differences in the relative contributions of competition versus 
selection by the environment. In the context of different types of household 
drains, this might result in differential exposure to one another and selection to 
inhibit one another, leading ultimately to differences among drain types in their 
inhabitants’ inhibition profiles. We evaluated the relationship between drain type 
and recovery rate and inhibition patterns to investigate potential contributions of 
local adaptation to different habitat associated with bathroom versus kitchen sink 
drains.  
Although there are indications that bacteriocin-mediated inhibition may not 
be directly predictive of competitive outcomes [55], there are two well studied 
hypotheses regarding the relationships between bacteria and whether or not 
bacteriocin-mediated inhibition should be favored [12, 14, 120]. First, if 
bacteriocins do contribute to the outcome of competitive interactions, it may be 
that bacteriocin-mediated inhibition will occur when two individuals have similar 
resource requirements, given that competition occurs over shared resources [12, 
14, 120, 121]. This is because while costly production of bacteriocins is not 
favored when niche overlap is minimal, it becomes more beneficial as niche 
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overlap increases. As niche overlap becomes even stronger, the capacity to 
inhibit the competitor may decrease not because there is insufficient benefit to 
bacteriocin-mediated inhibition, but because the competitors may be similar in 
their bacteriocin genotypes as well as their metabolic profiles, causing them to 
lack the capacity to inhibit one another [12, 120]. As such, we predict a “hump-
shaped” relationship between inhibition and metabolic dissimilarity in which 
inhibition is least favored among isolates with low and high resource overlap and 
is most likely to occur when interacting isolates share an intermediate number of 
resources. Previous studies have examined this relationship between resource 
competition and bacteriocin-mediated interactions but results vary in the degree 
to which they conform to this prediction [12, 14, 120]. 
Second, a hump-shaped relationship such that bacteriocin-mediated 
inhibition is maximized when two individuals are genetically related at an 
intermediate level [120] is also predicted. This is because bacteriocin production 
targeting very closely related isolates will not be favored, because shared 
phylogenetic history will cause closely related isolates to carry the same 
bacteriocin immunity genes and therefore not be killed by their shared toxins. 
Bacteriocin-mediated competition should also be minimal when two individuals 
are genetically distant if, along with other traits, their resource use overlap 
declines over evolutionary time. The hump-shaped relationship has been found 
among laboratory and clinical isolates of P. aeruginosa by Schoustra et al. [120], 
but other studies of environmental microbes have found contrasting evidence for 
this relationship [12, 14, 57]. 
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The goal of this study was to elucidate the underlying mechanisms that 
drive diversity in bacteriocin-mediated inhibition. Relationships among spatial 
scale, metabolic dissimilarity, genetic distance, and bacteriocin inhibition have 
been examined in different microbial systems with differing results. Furthermore, 
these patterns have not yet been studied in household isolates of P. aeruginosa, 
where the high production of pyocins [51, 55] suggests an important ecological 
role for these protein structures. We found the lowest probability of inhibition to 
be among isolates collected from the same drain and the highest probability of 
inhibition to be among isolates collected from different houses, and we identified 
additional substantial random variation among specific pairs of houses. No 
relationship was found between metabolic dissimilarity and inhibition; however, a 
significant hump-shaped relationship was found between genetic distance and 
inhibition, meaning that isolates of an intermediate genetic distance displayed the 
highest probability of inhibition.  
Methods 
Bacterial Isolate Sampling 
70 houses in the Louisville, Kentucky metropolitan area were sampled 
from June 2016-May 2017. Bathroom and kitchen sink drains were sampled 
using a sterile cell scraper. Samples from all 70 houses were collected in sterile 
1X PBS and stored at 4 C. Samples were plated onto cetrimide agar [122] and 
incubated at 37 C for 24-48 hours. If growth was observed on the plate, colonies 
were isolated and species-specific PCR primers were used to identify those 
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colonies that were P. aeruginosa [123]. 
 For the first 12 houses, up to 13 clonal picks were performed for each 
drain sample to maximize likelihood of recovery. Based on results of this 
sampling, a standardized protocol was used in sampling of houses 13-70. In 
these latter houses, the minimum of all colonies on a plate or up to seven 
colonies were isolated and P. aeruginosa was identified using a species-specific 
PCR reaction [123]. 
Across all 70 houses, nine houses yielded a total of 105 isolates. All P. 
aeruginosa isolated (105 isolates in all) were stored in 20% glycerol at -80 C. Of 
these, three isolates were randomly chosen from each of the two drain types 
(bathroom sink drain and kitchen sink drain) in all nine houses to be used in 
pairwise inhibition assays. This resulted in a total of 54 P. aeruginosa isolates for 
the pairwise inhibition assays. 
Pairwise Inhibition Assays 
The 54 (three isolates x two drain types x nine houses) isolates were 
tested for ability to inhibit and resist inhibition in all pairwise combinations 
according to the protocol described by Fyfe et al. [124]. Each pair was assayed 
three independent times, for a total of 2916 tests of inhibition. Briefly, individual 
clones of the 54 isolates were picked and used to inoculate 4 mL of LB broth. 
Each culture was grown for about 18 hours at 28 C with shaking at 250 rpm. 
After the initial incubation period, 10 L of this overnight culture was used to 
inoculate two tubes of 4 mL LB broth. Cultures were incubated with shaking at 28 
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C for 2-3 hours. Pyocin production was then induced in one culture (the 
“producer” culture) using mitomycin C, a DNA damaging agent that has been 
shown to induce bacteriocin expression [52, 83], to a final concentration of 2 
g/uL. The second, uninduced (“indicator”) culture was also incubated alongside 
the producer culture. 
After 16-18 hours incubation at 28 C, 5 L of the producer cultures were 
spotted onto LB plates and incubated for 6 hours at 28 C. 1.5 mL of chloroform 
was added to each plate to kill the producer colonies and plates were allowed to 
dry for 30 minutes. Producer colonies were killed prior to soft agar overlay to 
avoid the observation of inhibition due to a mechanism other than pyocin 
production, such as contact-dependent or secretion-mediated killing. In each 
experimental block, the indicator cultures were standardized to the lowest 
observed O.D.595 reading among the set of 54. Once standardized in this way, 
100 L of each indicator culture was used to inoculate 6 mL of soft agar, which 
was vortexed gently and poured over the agar surface of plates that had been 
spotted with killed producer cultures. Plates were left to incubate for 16-18 hours 
at 28 C. Zones of inhibition of the indicator isolates were identified by visual 
inspection. Cases of inhibition presented as either a clear, defined zone of 
inhibition (indicating R or F-type pyocin) or diffuse zone of inhibition (indicating S-
type pyocin inhibition); both inhibition phenotypes were considered cases of 
inhibition for the purposes of data collection. 
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Genetic Distance 
Genomic DNA was extracted from isolates using 1 mL of overnight culture 
and Wizard Genomic DNA purification kit (Promega, Madison, WI, USA). Genetic 
distances were estimated using Illumina whole genome sequencing and ARIBA, 
[125] which was used to extract seven housekeeping genes (ascA, aroE, guaA, 
trpE, mutL, nuoD, ppsA) used in a P. aeruginosa multilocus sequence typing 
scheme developed by Curran et al. [126]. These genes were concatenated and 
pairwise genetic distances were calculated using only the seven housekeeping 
gene sequences and R package ape [127] on RStudio version 1.1.453 [128].  
Resource Competition 
The ability of the 54 P. aeruginosa isolates to use 31 carbon sources was 
measured in triplicate using EcoPlates (Biolog, Hayward, CA, USA) and a 
protocol adapted from Schoustra et al. [120]. Cultures were grown overnight to 
stationary phase to a minimum O.D.595 of 0.8. Cultures were diluted by adding 10 
L of overnight culture to 10 mL of minimal salt media (N2HPO4 6.8 g, KH2PO4 3 
g, NaCl 0.5 g, NH4Cl 1 g, 1000 mL dH20). After a starvation period of two hours, 
plates were inoculated with 150 L of sample. The O.D.595 of all wells in the plate 
were measured immediately after inoculation (T0) and again after 48 hours of 
incubation at 28 °C. The absorbance measures from the 48-hour time point were 




To assess the differences in recovery from bathroom and kitchen sink 
drains, presence or absence of P. aeruginosa from each drain was analyzed 
using McNemar’s test in the set of 58 houses, which were sampled using a 
standardized sampling technique. 
Four generalized linear mixed models were performed with the SAS 
version 9.4 TS1M3 GLIMMIX procedure [130]. Models were run with LaPlace 
estimation and containment method of denominator degrees of freedom 
estimation. Self-on-self interactions were excluded from all analyses, as no 
inhibition was expected or observed in these controls. The results of the three 
replicate assays per pair were reduced to a dichotomous response variable, 
inhibition outcome by using the most common (2 out of 3) outcome when all 
three did not agree. 
We examined the importance of spatial scale by running a generalized 
linear mixed model with inhibition as a binary response variable and spatial scale 
as a categorical predictor variable. House of isolation was not included in this 
model as a predictor variable because it is confounded with spatial scale, but 
was evaluated in all other models. This was done by including the house of the 
producer, the house of the indicator, as well as the interaction between the two 
as random effects. We also tested the effect of drain type by running a 
generalized linear mixed model with inhibition as a response variable and 
producer drain type, indicator drain type, and the interaction between the two 
terms included as fixed predictor variables.  
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We explored the hump-shaped relationship between metabolic 
dissimilarity and inhibition by running a generalized linear mixed model with 
metabolic dissimilarity and the square of metabolic dissimilarity as predictor 
variables and call as the response variable. Similarly, we ran a generalized linear 
mixed model using genetic distance and the square of genetic distance as 
predictor variables and call on inhibition as the response variable.  
Results 
P. aeruginosa is rarely found in multiple drains within a house 
The bathroom and kitchen sink drains of 70 houses were sampled in the 
Louisville KY Metropolitan area. 58 of these 70 houses were sampled using a 
standardized sampling protocol; this subset of houses was used for analysis of P. 
aeruginosa recovery. Of these 58 houses, 22 yielded P. aeruginosa from at least 
one drain with an overall recovery of roughly 37%. P. aeruginosa was collected 
from the bathroom sink drain only in 11 houses (19%), from the kitchen sink in 
only five houses (9%), and from both the bathroom and kitchen sink drain in six 
houses (10%). Despite slightly higher recovery from bathroom sink drains than 
from kitchen sink drains, this analysis identified no significant difference in 
recovery from the two drain types (p=0.21, McNemar’s Test).  
Inhibition varies across space 
We tested an isolate’s ability to inhibit using an agar overlay method from 
a well-established protocol [124], which uses the DNA damaging agent 
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mitomycin C, to induce bacteriocin expression. Pairwise interactions were 
conducted, meaning that each isolate was examined as both a “producer” and as 
an “indicator.” As a producer, an isolate was treated with mitomycin C and was 
tested for its ability to kill a non-induced strain, termed the indicator. Although the 
presence of pyocins was not directly confirmed during the inhibition assays, the 
presence of pyocin genes within the isolates used in these assays was confirmed 
comparison to the with BAGEL database [131](A.A.M., unpublished data). 
Additionally, zones of inhibition observed in the assays presented as diffuse or 
clear zones of inhibition, and did not present as plaques that would be expected 
if bacteriophage was responsible for killing. Previous studies have also 
repeatedly shown that an induction with mitomycin C is a reliable method to 
induce the expression of pyocin genes [52, 83]. Additionally, no cases self-
inhibition were observed in the assays, suggesting that pyocins indeed were 
responsible for the zones of inhibition as each isolate should carry an immunity 
gene to its own toxin [132]. 
Self-on-self interactions, as expected, never resulted in inhibition (white 
squares, Fig. 4). Of the remaining 2862 pairwise interactions, overall, 944 (33%) 
resulted in inhibition. The interactions in this study were observed across three 
spatial scales: within the same drain, between different drains in the same house, 
and across different houses. No inhibition was observed between isolates 
collected from the same drain (dark grey squares, Fig. 4). Inhibition was 
observed among isolates collected from different drains in the same house in 
three of nine houses (dark green squares). The majority of inhibition was 
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observed among isolates collected from different houses (dark blue squares). A 
generalized linear mixed model assessing dependence of the outcome of the 
inhibition assay on spatial scale showed that as distance increased, there was a 
significantly higher probability of inhibition (Fig. 5, p<0.0001; Table 1).  
We also examined patterns of pyocin inhibition and susceptibility among 
isolates collected across different houses through the inclusion of house as a 
predictor variable in generalized linear mixed models with metabolic and genetic 
distance. We found significant variability attributable to both the house of the 
producer and the house of the indicator. In other words, whether or not a 
producer is able to inhibit an indicator depends on the house of isolation for both 
interacting isolates (Fig. 4). Therefore, these results suggest that, in addition to 
scale, there is random stochasticity across space that contributes to diversity in 
pyocin phenotype. 
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Figure 4. Pairwise inhibition assay outcomes. Light grey boxes with letters 
represent the nine houses from which bathroom and kitchen sink isolates were 
collected. Yellow and orange boxes represent isolates obtained from bathroom or 
kitchen sink drains, respectively. Pairwise interaction assay results were color 
coded based on a call on the outcome of inhibition, which was made if two out of 
three interactions resulted in inhibition. White squares represent no self-
inhibition. Dark blue squares represent inhibition among isolates collected from 
different houses. Dark green squares represent inhibition among isolates 
collected from the same house and dark grey squares represent no inhibition 
observed among isolates collected from the same drain. Cases of non-inhibition 
across houses are indicated in light blue and cases of non-inhibition between 
drains of the same house are indicated in light green.  













Figure 5. Predicted probability of inhibition when isolates are collected at 
different spatial scales. Least-squares means with 95% confidence intervals 
display the predicted probability of the producer isolate to inhibit the indicator 
isolate. Different letters indicate significant differences in means at alpha=0.05 
after correcting for multiple comparisons using the Tukey-Kramer adjustment. 

























Scale Mean percentage of inhibition
Within a drain 0
Between drains 23.5 %
Across houses 34.9 %
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Inhibition varies with drain type 
Previous studies have shown that bathroom and kitchen sink drains often 
differ in their recovery of P. aeruginosa [72, 74]. Based on these differences in 
recovery between drain types, we hypothesized that isolates collected from 
different drain types may differ with respect to their pyocin inhibition or 
susceptibility. To address this, pyocin inhibition was measured across two 
different household drain types: bathroom sink drains and kitchen sink drains. A 
generalized linear mixed model was run with producer drain type, indicator drain 
type, and the interaction between these two terms as fixed effects. We found that 
the inhibition observed was strongly affected by the particular combination of 
drain types from which the producer and indicator isolates were obtained 
(interaction effect, p=0.05). In particular, when indicators from kitchen sink drains 
were challenged with producers from bathroom sink drains, significantly less 
inhibition occurred in comparison to interactions between any other combination 
of isolation sources, and none of the other combinations resulted in differences in 
inhibition (Fig. 6). The detection of overall greater capacity to inhibit and greater 
resistance to being inhibited among kitchen sink isolates (producer main effect, 
p=0.0248, indicator main effect, p=0.0026) is likely driven by this single 
combination of drain types. 
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Figure 6. Predicted probability of inhibition within isolates collected from different 
drain types. Predicted probabilities of inhibition are least-squares means with 
95% confidence intervals. Different letters indicate significant differences in 
means at alpha=0.05 after correcting for multiple comparisons using the Tukey-
Kramer adjustment. 
Metabolic dissimilarity does not predict inhibition 
To determine if metabolic dissimilarity is an important predictor of the 
outcome of inhibition, we measured resource use of 31 different carbon 
resources using EcoPlates (Biolog, Inc., Hayward, CA, USA) and calculated 
pairwise metabolic dissimilarities. We then ran a generalized linear mixed model 
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square of metabolic dissimilarity as predictor variables (Table 2). Neither 
metabolic dissimilarity nor its quadratic term was found to be significant in the 
model (p=0.4905 and 0.7486, respectively). Therefore, we found no evidence of 
a hump-shaped relationship between metabolic dissimilarity and inhibition. These 
results indicate that competition mediated by differential use of these common 
carbon sources may not play an important role in determining the outcomes of 
inhibitory interactions. 
Table 2. Generalized linear mixed model testing the effect of metabolic 
dissimilarity and the square of metabolic dissimilarity as well as various random 
effects on the outcome of inhibition. 
Genetic distance has a hump-shaped relationship with inhibition 
To determine if genetic distance has a hump-shaped relationship with 
inhibition, we measured genetic distance using differences among isolates’ 
Effect Estimate DF Test Statistic⨥
Metabolic Dissimilarity 2.5926 2515 0.48
Metabolic Dissimilarity2 2.6765 2515 0.1
Producer House 0.2240 0.76
Indicator House 0.9343 1.47
Draincomboordered 0.03819 0.1611
Producer House*Indicator House 2.4890 3.89***
⨥Fixed effect is tested with an approximate F test. Random effects are tested using Wald Z tests.
* 0.01 < p < 0.05
** 0.001 < p < 0.01
*** p < 0.001
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sequences at seven housekeeping genes in the P. aeruginosa genome. We 
looked to see if inhibition occurs most frequently at an intermediate genetic 
distance by running a generalized linear mixed model with inhibition as the 
response variable and genetic distance and the square of genetic distance as the 
predictor variables (Table 3). This model identified a significant positive value for 
the parameter estimating the linear effect of genetic distance (p<0.0001) and fit a 
negative parameter estimate for the effect of the square of genetic distance 
(p=0.0006). These estimates model the predicted hump-shaped relationship for 
genetic distance and bacteriocin-mediated interactions in which these 
interactions are predicted to occur most frequently when two isolates are 
intermediately genetically related (Fig. 7). 
Table 3. Generalized linear mixed model testing the effect of genetic distance 
and the square of genetic distance as well as various random effects on the 
outcome of inhibition. 
Effect Estimate DF Test Statistic⨥
Genetic Distance 308.18 1871 17.84***
Genetic Distance2 -17798 1871 11.97***
Producer House 0.2110 .
Indicator House 0.9595 1.40
Draincomboordered 0.05152 .
Producer House*Indicator House 2.2006 3.89***
⨥Fixed effect is tested with an approximate F test. Random effects are tested using Wald Z tests.
* 0.01 < p < 0.05
** 0.001 < p < 0.01
*** p < 0.001
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Figure 7. Predicted probability of inhibition with genetic distance. The line is 
plotted using estimates from the generalized linear mixed model run to examine 
the effect of genetic distance and the square of genetic distance on the outcome 
of inhibition. Points represent frequency of inhibition for each measure of genetic 
distance, calculated by averaging call on the outcome of inhibition among all 
interacting isolates of a particular genetic distance.  
Discussion 
P. aeruginosa is not ubiquitous in household drains 
In this study, we found a greater percentage of drains containing P. 
aeruginosa than in previous sampling studies done by our group (37% as 
opposed to 15 and 28%) [73, 74]. The sensitivity of detection of P. aeruginosa 
























































based sampling employed the more species-specific medium cetrimide rather 
than Pseudomonas Isolation Agar [122], and more isolates were collected per 
sample taken. However, despite our intensive sampling focused on the single 
type of site in the house where P. aeruginosa has previously been shown to most 
frequently inhabit, and despite higher recovery in this study from each drain type 
than in those previous studies, we found that the proportion of houses from which 
P. aeruginosa was recovered from both bath and kitchen sink drains was still 
relatively low (10%). This suggests that, in addition to dispersal into the house, 
within-house forces such as dispersal limitation or selective differences between 
bathroom and kitchen sink drains limit the distribution of this species. This is 
notable in part because it runs counter to the traditional characterization of this 
species as a ubiquitous generalist [62, 133]. 
Inhibition increases with scale and varies with house 
In our assays, we found that inhibition increases with the separation in the 
isolation sites of the producer and indicator (Fig. 2). This suggests that the 
selective pressure from pyocin producing isolates of P. aeruginosa may have 
eliminated diversity with respect to this phenotype at the within-drain level. 
Isolates within the same drain have either co-evolved as to not be susceptible to 
the particular pyocins being produced within a single drain, or pyocin sensitive 
isolates have been competitively excluded by producer isolates. In contrast, 
isolates taken from different houses that were less likely to have interacted, 
showed greater diversity in pyocin phenotypes, and were able to inhibit one 
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another. The positive relationship among inhibition and increasing spatial scale is 
consistent with those of previous studies in Pseudomonas fluorescens and in 
species of the Xenhorhabdus genus [12, 57]. Although, this trend was not 
observed among soil pseudomonads by Kraemer et al. [14], the scale on which 
the isolates were collected in that study may have been too large to detect a 
relationship with inhibition. Unlike studies done in other Pseudomonas species 
and species in the Xenhorhabdus genus [12, 14, 57], we found a much higher 
frequency of inhibition among isolates overall, which is likely explained by the 
highly abundant production of pyocins in P. aeruginosa, and particularly in 
environmental isolates of P. aeruginosa [51, 55]. 
Previous studies have shown that spatial structure in microbial populations 
may lead to a decrease in local population diversity, but an increase in overall 
diversity across larger spatial scales [12, 14, 57]. In laboratory strains of 
Escherichia coli, it has been demonstrated that in unstructured environments 
such as a broth culture, bacteriocin production will lead to a decrease in diversity 
as one strain will competitively exclude the other. However, in a structured 
environment such as that of an agar plate, competitive interactions occur more 
locally, which allows for the coexistence of multiple bacteriocin phenotypes [34]. 
Similarly, Inglis et al. [54] also found that a pyocin producing strain of P. 
aeruginosa has increased fitness relative to a non-pyocin producer under 
conditions of local competition. This is because, when competition is localized, 
individuals that are genetically related to the bacteriocin producer are close by 
and are likely to benefit as bacteriocin production frees up resources. High rates 
53 
of dispersal, however, will cause competition to occur more globally and 
bacteriocin production will provide less of a fitness benefit. Based on the results 
of our sampling study, it appears that P. aeruginosa dispersal among houses, 
and, to a lesser extent, within the houses, could potentially be limited. Moreover, 
even accounting for differences among drain type, metabolic similarity, and 
genetic distance, significant variability in pyocin phenotype was detected among 
P. aeruginosa isolated from different houses. This further supports our 
conclusion that dispersal limitations across different houses leads to the 
maintenance of diversity in inhibitory interactions. Further investigation into the 
relationship between highly patchy environments, like the built environment, and 
diversity in bacteriocin inhibition in this species and others is warranted. 
Local adaptation to drain type may influence inhibition 
Previous sampling studies have yielded varying results regarding the 
difference in P. aeruginosa recovery from bathroom and kitchen sink drains, with 
either greater recovery from bathroom drains [72, 74] or no differences detected 
[71, 73]; our study showed a non-significant trend toward greater recovery in 
bathroom drains. In evaluating possible differences in the outcome of inhibition 
assays with respect to isolates’ house drain types, we observed differences in 
the pyocin inhibition and sensitivity profiles. We found that inhibition assay 
outcomes depended on the drain types of interacting isolates. This suggests that 
local adaptation to drain type may be at play and responsible for differences in 
the competitive interactions among those isolates.  
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While we have not explored the particular ecological differences between 
bathroom and kitchen sink drains, there may be both abiotic and biotic 
components of these drain types that could contribute to local adaptation of P. 
aeruginosa isolates. For example, there could be differences in available 
resources or in microbial community compositions, either of which could affect 
selection through competitive interactions among P. aeruginosa. Future studies 
in this area could work to clarify the differences in drain types with respect to both 
abiotic and biotic factors. 
Resource competition does not drive inhibition 
We looked for differences in resource use among isolates to test the 
prediction that resource dissimilarity may help predict inhibitory interactions [12, 
14, 120], but found no evidence of such a relationship. Schoustra et al. [120] 
observed the frequency of inhibition to peak at intermediate resource usage 
overlap among clinical and laboratory P. aeruginosa isolates. Differences 
between our results and that study could be due the fact that we used only 
environmental isolates, not clinical isolates and laboratory strains. Kraemer et al. 
[14] found metabolic dissimilarity to negatively correlate with frequency of 
inhibition, while Bruce et al. [12] similarly found that inhibition was significantly 
higher between isolates with greater niche overlap, suggesting that competition 
for shared resources may play an important role in the selection for and 
maintenance of bacteriocin production. This could occur if outcompeting other 
isolates with similar resource requirements through bacteriocin production 
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liberated limited resources and provided the bacteriocin producing strain with a 
competitive advantage. The differences between the findings in our study and the 
outcomes of Bruce et al. [12] and Kraemer et al. [14] could be attributed to the 
fact that Kraemer et al. [14] were likely examining relationships among different 
Pseudomonas species rather than within one species, and Bruce et al. [12] 
calculated niche overlap as opposed to metabolic dissimilarity as we did. 
Although we detected no significant relationship between metabolic dissimilarity 
and pyocin inhibition profile, we note that there are many ways in which resource 
similarity could differ among isolates that would not be detectable in our assay, 
particularly in light of the known metabolic versatility of P. aeruginosa [62]. 
Additionally, the carbon resources in Biolog EcoPlates are biased toward 
plant-based carbon sources, which are likely different from the carbon sources 
available in sink drains. Future work addressing metabolic similarity could 
explore other resources over which competition might be occurring such as 
alternative carbon sources, nitrogen sources, and other bacterial nutritional 
requirements that might be more available to isolates in sink drains. It can also 
be noted here that Bara et al. [55] found that the ability to inhibit another isolate 
via pyocin production does not always predict overall competitive ability, so it is 
possible that pyocin inhibition does not play a critical role in competition and 
therefore is unrelated to resource use. As such, future investigation into the 
specific ecological functions of pyocins could further illuminate the maintenance 
of these antibiotics in microbial populations. 
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Inhibition is most favored at an intermediate genetic distance 
We examined the relationship between genetic distance and patterns of 
inhibition among the isolates in this study and found strong evidence to support a 
hump-shaped relationship. These results are consistent with the predicted hump-
shaped relationship that was observed by Schoustra et al. [120], though not with 
those of Hawlena et al. [57], Kraemer et al. [14] and Bruce et al. [12], which 
examined such relationships among more distantly related taxa and used 
different approaches to measuring genetic distance.  
Because the measure of genetic distance that we used is based on 
sequence comparison of conserved housekeeping genes, it measures genetic 
similarity based on phylogenetic history, and is not mechanistically driven by 
selection on pyocin use. We know that bacteriocin production in P. aeruginosa, 
particularly in household isolates [55], is much more common than that of other 
Pseudomonas and bacterial species [51]. Thus, the hump-shaped relationship 
between this form of genetic distance and inhibition patterns could be caused by 
widespread use of pyocins and restricted movement in space, which shape the 
population genetic structure of this species. We note that other measures of 
genetic distance could reveal additional evolutionary dynamics affecting patterns 
of pyocin interactions. For example, a decline in killing at greater genetic distance 
can occur if more genetically distant bacteria lack the particular cell surface 
receptors required for bacteriocin binding [95, 105, 132]. Such patterns would be 
better detected using measures of genetic distance based on gene content or 
gene sequence of pyocin associated genes such as toxin, immunity, regulatory, 
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and receptor synthesis genes. Use of such different genetic distance measures 
might not reveal the hump-shaped relationship that we detected with our 
measure. 
Conclusion 
In this study, we explored many potential driving forces of diversity in 
pyocin-mediated inhibition using isolates collected from spatially structured 
bathroom and kitchen sink drains across nine different houses. Differences in the 
outcome of inhibition among isolates from different drain types and among 
isolates differing in their genetic distance suggest roles for local adaptation 
and/or limited local dispersal, and a signature of phylogenetic history in 
maintaining pyocin diversity. However, we also found strong patterns indicating 
an important role for dispersal limitation at a landscape level in driving patterns of 
pyocin-mediated inhibition. When combined with competitive exclusion within a 
drain, dispersal limitation can explain an increase in inhibition with spatial scale 
and random house-to-house variation in patterns of inhibition. 
58 
CHAPTER III 
GENETIC PATTERNS OF PYOCIN DIVERSITY IN HOUSEHOLD 
PSEUDOMONAS AERUGINOSA  
Summary 
Bacteriocins are narrow-spectrum antibiotics, meaning that the killing capacities 
of these antimicrobials are typically restricted to the same species or closely 
related species. Pseudomonas aeruginosa, a Gram-negative opportunistic 
pathogen, is characterized by the diverse and abundant nature of putative 
bacteriocin genes found in this species, called pyocins in this system. Diversity in 
pyocin gene content has been reported in clinical isolates of P. aeruginosa, 
particularly in those isolated from individuals with Cystic Fibrosis (CF), but 
patterns of diversity in pyocin gene content, as well as the ecological and 
evolutionary underpinnings of these patterns, is not well-characterized in 
environmental isolates. Furthermore, it is unclear how pyocin genes contribute to 
outcomes of inhibition. We sequenced genomes of 46 isolates collected from 
bathroom and kitchen sink drains across eight houses and searched the 
genomes for 11 well-characterized pyocin genes. We previously examined 
pyocin inhibition among these isolates using pairwise inhibition assays. We found 
that isolates across houses differed primarily with respect to immunity 
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genes while isolates collected from bathroom sink drains encoded significantly 
more pyocin genes than those collected from kitchen sink drains. We also found 
that isolates carrying immunity genes were less likely to be inhibited and that 
isolates carrying only R-type pyocin killing genes had the highest likelihood of 
inhibition. These findings suggest that current environmental conditions in 
different drain types and, to a lesser extent, spatial isolation across houses 
contribute to differences in pyocin gene content. Furthermore, while some 
patterns of inhibition can be related to pyocin genotypes in interacting isolates, 
there are likely more factors in this complex system contributing to these 
observed patterns including differential expression of pyocin genes and 
alternative mechanisms of resistance. 
Introduction 
Bacteriocins are highly-prevalent narrow-spectrum antibiotics, meaning 
that the killing capacities of these proteinaceous antimicrobials are typically 
restricted to the same species or closely related species [48].  The bacteriocins 
of Pseudomonas aeruginosa, called pyocins, are chromosomally encoded and 
can be distinguished from other bacteriocin systems due to the high abundance 
of pyocin genes in this species, as nearly all strains of P. aeruginosa carry genes 
for at least one pyocin. Additionally, these antimicrobials are highly diverse and 
composed of three types: S, R, and F. The S-type pyocins share homology to the 
system of bacteriocins in Escherichia coli in that these antimicrobials are 
composed of two genes: one gene encoding a protein responsible for killing 
activity and one gene encoding a protein that binds to an inactivates the killing 
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protein, thus providing immunity for a producing cell as well as potential target 
cells [80, 86]. S-type pyocins must bind to cell surface receptors and be 
translocated into a target cell for the killing activity to occur [103]. The receptors 
for many S-type pyocins are receptors for iron-binding molecules called 
siderophores [93-95, 102, 134]; in addition to the presence of a cognate immunity 
gene, it is thought that resistance to S-type pyocins may also come from receptor 
alteration such that the pyocins can no longer bind. While it is presumed that the 
immunity protein is needed for a producer cell to have protection against its own 
pyocin activity, previous studies have found many occurrences of “orphan” genes 
in which either killing or immunity genes are present singly [55, 88]. Due to the 
presence of these so-called “orphan” genes, and in particular, those instances in 
which killing genes are present alone, it is unclear if pyocin immunity genes 
always provide immunity to a target cell and if immunity genes are essential for a 
cell to be resistant to an associated killing protein. 
R- and F-type pyocins, collectively referred to as talocins, are ancestrally 
derived from bacteriophage; when produced, these pyocins are multi-subunit 
protein complexes that resemble headless phage tails [83]. Like the S-type 
pyocins, the talocins target specific receptors on the surface of a target cell; 
however, for the talocins, these receptors are lipopolysaccharides (LPS) [104, 
105]. Unlike S-type pyocins, talocins act through pore formation, leading to 
membrane depolarization in a target cell. Talocins are not accompanied by 
immunity genes, and instead, resistance is mediated through receptor 
incompatibility due to differences in LPS composition. There are 5 R-subtypes 
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(R1-R5) and 3 F-subtypes (F1-F3) that differ only with respect to tail fiber 
composition, which accounts for receptor specificity and, therefore, the killing 
spectra of these pyocins. The genes encoding R- and F-type pyocin structural 
proteins are located together in the P. aeruginosa genome between two 
genes: trpE (anthranilate synthase component I) and trpG (anthranilate synthase 
component II) in the genome. Within this region, there are 
genes, prtR and prtN, which encode regulatory proteins and are involved in the 
expression of pyocin genes [83]. PrtR is a protein that acts as a repressor for 
pyocin expression under normal conditions, and PrtN is a protein that serves as 
an activator of pyocin expression under stressful conditions such as those 
involving low nutrients or the presence of a mutagenic agent [81, 82]. The S-type 
pyocins are located elsewhere in the genome, often near the toxA gene 
(encoding exotoxin A) [89]; however, it is predicted that the expression of S-type 
pyocin genes is also regulated by the same system as that of R and F-type 
pyocins [81]. Also located within the R/F gene cluster are a group of putative 
genes that are believed to encode lytic enzymes, which would enable cells 
producing pyocins to release these antibiotics in the presence of target cells [83]. 
Previous studies have found evidence that R-type pyocins may play a 
significant role in mediating the outcomes of inhibitory interactions in laboratory 
settings [135]. However, the vast majority of these studies focus on pyocin-
mediated interactions among clinical isolates and, because P aeruginosa causes 
chronic lung infections in individuals with cystic fibrosis (CF) [60], the most 
commonly studied clinical isolates are derived from these infections.  The 
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contribution of R-type pyocins to the outcomes of inhibitory interactions in non-
clinical isolates of P. aeruginosa has not been extensively investigated. We 
anticipate that the roles of R-type pyocins could differ from those previously 
reported based on phenotypic and genotypic differences in environmental and 
clinical isolates. Furthermore, it is also of interest to detect patterns of inhibition 
among isolates concurrently producing different combinations of pyocin killing 
genes, as this has not yet been investigated and should be of particular 
relevance because a large proportion of P. aeruginosa isolates have been found 
to carry multiple pyocin genes. 
We sequenced 46 genomes from a collection of P. aeruginosa isolates 
derived from eight different spatially isolated households in the Louisville, KY 
metropolitan area and searched the genomes for pyocin genes. The spatial 
structure of the isolate collection allowed us to investigate the influences of 
historical processes such as dispersal limitations. Additionally, these isolates 
were collected from bathroom and kitchen sink drains, which provided a 
collection comprised of isolates likely experiencing different abiotic and biotic 
conditions, allowing us to explore the effects of contemporary conditions on 
pyocin diversity.  The pyocin-mediated killing patterns were previously described 
[136]. The first aim of this study was to characterize overall diversity in pyocin 
gene content among isolates in our strain collection and to elucidate the 
mechanisms underlying this diversity. The second aim of this study was to 
uncover the relationship between pyocin genotype and the outcome of inhibitory 






pyocin killing genes would have a higher likelihood of inhibition than isolates 
carrying fewer killing genes. We also hypothesized that indicator isolates carrying 
immunity genes would have a lower likelihood of being inhibited when compared 
to isolates that do not carry immunity genes.  
 We found that isolates from different houses differ primarily with respect to 
the total number of immunity genes found in each isolate, but do not significantly 
differ in the total number of all pyocin genes, suggesting a weak relationship 
between historical events and pyocin gene content. Isolates collected from 
bathroom sink drains encoded significantly more killing and immunity genes, 
indicating that the current conditions, either abiotic or biotic, may play an 
important role in shaping patterns of diversity in pyocin genetics. Finally, isolates 
with S-type immunity genes have a significantly lower probability of being 
inhibited by S-type killing proteins, and isolates producing only R-type pyocins 
exhibit the highest likelihood of inhibition than all other killing gene combinations. 
While pyocin genotype was found to be an important predictor in the outcome of 
inhibition, pyocin killing and immunity genes alone do not account for the 
variability in inhibitory interactions, and we hypothesize that other factors such as 
receptor specificity and gene expression further contribute to patterns of 
inhibition. 
 
Materials and Methods 
Strain collection 
The bathroom and kitchen sink drains of 70 households in the Louisville, 
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KY metropolitan area were sampled from June 2016-May 2017. The methods for 
sampling and P. aeruginosa identification were performed as described in a 
previous study [136]. Strains were maintained in LB unless otherwise noted.  
Pairwise inhibition assays were previously reported in [136].  
Pyocin inhibition assays 
Of the 105 P. aeruginosa isolates, three isolates were randomly selected 
from each drain, resulting in a total number of 54 isolates used in the inhibition 
assay (nine houses x two drains x three isolates). Three biological replicates of a 
54x54 pairwise inhibition assay were performed according to previously 
described methods [136].   
Genetic analyses 
Purified DNA was obtained from P. aeruginosa isolates grown overnight at 
37°C in LB broth using the Wizard Genomic DNA Purification Kit (Promega, 
Madison, WI, USA).  Paired-end Illumina sequencing was performed on 46 of the 
54 isolates in our strain collection at the Roy J. Carver Biotechnology Center at 
the University of Illinois Urbana-Champaign on an Illumina MiSeq machine. 
Trimmomatic [137] was used to trim raw reads, and SPAdes [138] was used to 
assemble the genomes. Default settings were used for both trimming and 
assembly. 
The website http://pseudomonas.com [139] was used to retrieve all 
putative pyocin gene sequences of interest in this study (Appendix, Tables 4 & 
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5). CLC Genomics Workbench (Qiagen, Germantown, MD, USA) was used to 
create a custom BLAST database of the genome assemblies in this study. A 
tblastx was performed to search for complete pyocin gene nucleotide sequences. 
Default settings for tblastx were used. The statistical significance threshold used 
was 10; the scores for a nucleotide match and penalty for a nucleotide mismatch 
were 1 and -2, respectively. To confirm the accuracy of the BLAST results, 
publicly available genomes (Appendix, Tables 4 & 5) reported in the literature to 
harbor specific pyocin genes of interest were added to the custom BLAST 
database along with the genomes in our collection and served as reference 
genomes.  
Genomes were screened for S-type pyocins S1, S2, S3, S5, and AP41 
(Appendix, Table 4).  To determine if an R or F-type pyocin was present in our 
genomes, the sequences of all annotated genes between trpE and trpG in the 
genome of PAO1 [62] (Appendix, Table 5), which is known to carry genes for 
both R and F type pyocins, were used as query sequences in BLAST searches of 
our genomes. R-type pyocin genes were considered present if an isolate was 
found to have nucleotide sequences annotated with the locus tags PA0616-
PA028, which are putative genes in PAO1 that encode for structural components 
of R-type pyocins. It should be noted that isolates carrying R pyocin genes 
differed at locus PA0621, which is logical as this gene is presumed to encode for 
tail fiber proteins, which vary across different R-type pyocin subtypes. F-type 
pyocin genes were considered present if an isolate was found to have nucleotide 
sequences annotated with the locus tags PA0632-PA040, which are putative 
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genes in PAO1 that encode for structural components of F-type pyocins 
(Appendix, Fig. 8). Genes with the locus tags PA0643-PA0648 are believed to 
encode tail fiber proteins and, as such, sequences are variable in this region. 
Genes were considered present if the hits in our set of genomes mirrored those 
of the reference genomes, which have been reported in the literature to carry 
particular pyocin genes. For all genes considered present, the percent identity, 
which represents the percentage of identical residues between the query and hit 
sequence, was at least 94% and the sequence overlap, a percentage value for 
the overlap of the query sequence and hit sequence, was at least 80%. If a gene 
was considered present, it was coded in the dataset as “1,” and if a gene was 
considered absent, it was coded as “0.” 
Statistical analyses 
All analyses were performed in R Studio Version 1.3.959 [128]. R package 
emmeans [140] was used to calculate estimated marginal means from the 
generalized linear models.  
Two generalized linear mixed models (GLMER) were used to assess the 
differences among houses with respect to the total number of pyocin genes 
encoded in each isolate. The total number of pyocin killing genes, immunity 
genes, and total number of genes (killing + immunity) were calculated for each 
isolate. The sum of pyocin genes was a categorical response variable, house 
was used as a categorical predictor variable, and drain type was included as a 






converge when drain type was included as a random effect so it was dropped 
from this analysis, and a generalized linear model (GLM) was used. The Poisson 
distribution was used in all of these analyses.  
 Three generalized linear mixed (GLMER) models were used to assess the 
differences among drain types (bath versus kitchen) with respect to the number 
of pyocin killing genes, immunity genes, or the total number of pyocin genes 
(killing + immunity). The sum of pyocin genes was a categorical response 
variable, drain type was a categorical predictor variable, and house was included 
as a random effect. The Poisson distribution was used in the analyses.  
 To assess whether the presence of an S-type immunity gene contributed 
to the outcome of inhibitory interactions among our isolates, we subset the data 
such that all inhibitory interactions included only cases in which the producer 
isolate carried a single S-type pyocin killing gene; this included isolates carrying 
an S1 killing gene and isolates carrying an S2 killing gene. None of the isolates in 
our study were found to encode a single S-type pyocin gene without also carrying 
talocin genes and, due to this, the producer isolates used in this dataset carried 
either S1 and R-type pyocin genes, S2 and F-type pyocin genes, or S2 with R- 
and F-type pyocin genes. A call was made on the outcome of inhibition based on 
the results of the triplicate assays performed. If at least two out of three 
interactions resulted in inhibition, then a call of inhibition was made and coded as 
“1.” If one or no interactions resulted in inhibition, then a call of no inhibition was 
made and coded as “0.” Self-on-self interactions were excluded from the analysis 
because, as expected, none of these interactions resulted in a case of inhibition. 
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A generalized linear mixed model was run using call on the outcome of 
inhibition as a binary response variable with the presence or absence of an S1S2 
immunity gene in the indicator isolate as a binary predictor variable, “1” meaning 
an S1S2 immunity gene was found to be present in the genome of the indicator 
and “0” meaning the gene was determined to be absent. House of the producer 
and house of the indicator were included as random effects in the model. The 
model would not converge when the interaction between these two random 
effects was included and, as such, the interaction was dropped from the analysis. 
Inclusion of drain type of the producer isolate or drain type of the indicator isolate 
did not significantly improve the fit of the model, and therefore, these terms were 
also dropped from the analysis. The binomial distribution was used in this 
analysis. 
To investigate differences in inhibitory capacity among isolates carrying 
genes encoding different combinations of pyocins, we subset the data such that 
all inhibitory interactions included cases in which the indicator did not carry any 
S-type immunity genes (S1/S2, S3, S5, AP41) as we were only interested in the 
effect of killing gene combinations on the outcome of inhibition. First, to examine 
the relative contributions of each of the pyocin types (S, R, and F) to the outcome 
of inhibition, we ran three generalized linear mixed models with call on the 
outcome of inhibition as a binary response variable and presence of at least one 
S-type pyocin gene, presence of an R-type pyocin gene, or presence of an F-
type pyocin gene as categorical predictor variables. House of the producer 
isolate and house of the indicator isolate were included as random effects. The 
69 
binomial distribution was used in all three of these analyses. 
Then, to assess the differences in inhibition capacity among isolates 
carrying combinations of pyocin killing genes, we created a variable that 
encompassed each of the seven pyocin killing gene combinations found in our 
isolate collection: R, S2-F, S1-R, S1-S5-R-F, S1-AP41-R, S2-R-F, and S3-R-F. 
T. A generalized linear model was run with call on the outcome of inhibition as a 
binary response variable and pyocin killing gene combination as a categorical 
predictor variable. Variables defining the house of the producer isolate and the 
house of the indicator isolate were included as random effects. The interaction 
between these two terms did now allow for convergence of the model so it was 
dropped from our analysis. Drain type of the producer and drain type of the 
indicator did not significantly contribute to the fit of the model, and therefore, 
these terms were dropped from the analysis. The binomial distribution was used 
in this analysis.  
Results 
We previously assembled a collection of P. aeruginosa isolates from 
spatially structured sink drains with three isolates from each bathroom drain, and 
three isolates from sink drains for each of the eight houses in the study. We used 
whole genome sequencing of these isolates to search for genes encoding with S-
type pyocin and immunity proteins.  The genomes of each isolate were also 
probed for R- and F-type pyocins often found between the trpE and trpG genes in 
the P. aeruginosa genomes (Appendix, Fig. 8). Approximately half the isolates 
70 
had seemingly intact R- and F-type pyocin loci, while the remaining 50% did not.  
All isolates were found to encode PrtR and PrtN, the repressor and activator, 
respectively, responsible for pyocin gene expression [81, 82].  With this summary 
of pyocin gene content, we sought to identify patterns of diversity based on these 
pyocin genotypes. 
Overall patterns of diversity in pyocin genotype 
We searched whole genome sequences of 46 P. aeruginosa isolates in 
our study for complete nucleotide sequences of 11 currently described pyocin 
genes. Overall, the isolates in our collection were found to carry, on average, 
2.67 pyocin genes with killing and immunity gene averages of 2.15 and 0.52, 
respectively. We calculated the percentage of the isolates in our collection found 
to carry each gene (Fig. 9A). We then examined the complete pyocin genotype of 
each isolate with respect to the pyocin genes examined in this study including S-
type pyocin killing and immunity genes as well as genes of the talocins, R and F 
(Fig. 9B). We found that all 46 isolates in this study carry at least one pyocin 
gene, with a large number (76% or 35/46) carrying more than one gene. We 
found the R-type pyocin to be the most commonly found gene as it appeared in 
63% (29/46) of our isolates, followed by the F-type pyocin, which was found in 
56.5% (26/46) of our isolates. S2 pyocin, S1 pyocin, and S1/S2 immunity 
proteins were the next most commonly found pyocin genes with percentages of 
43.5, 32.6, and 32.6, respectively. In contrast, the rest of the pyocin killing and 
immunity genes (S3, S5, and AP41) were found at much smaller frequencies 
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(3/46 or 6.5% for all). Overall, 82.6% (38/46) of the isolates carried at least one 
S-type pyocin, and all isolates (46/46) carried at least one talocin. We note that 
all strains carrying a gene encoding a S-type pyocin also carry a gene encoding 
the cognate immunity protein except for strains with genes bearing S2 pyocins. 
We found seven unique gene combinations of pyocin killing and immunity 
genes (Fig. 9B). The highest percentage of strains carried genes encoding for 
the S2 and F-type pyocin (17/46 strains or 37% of isolates). This gene 
combination was followed by isolates encoding S1 pyocin, S1/S2 immunity 
protein, and R-type pyocin (9/46 or 19.6%) and isolates only encoding an R-type 
pyocin (8/46 or 17.4%).  The remaining pyocin genotypes were found in three of 
the 46 isolates in this study (6.5%).  Notably, while pyocins S1, AP41, S3, and S5 
are always found along with their cognate immunity genes, the S2 pyocin never 
appears with its associated immunity protein, S1/S2 immunity protein.  
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Figure 9. Diversity in pyocin gene (A) and genotype (B) among the isolates in 
our study. Percentages of isolates in our collection carrying each of the 11 pyocin 
genes (A) and percentages of isolates in the study carrying each of the pyocin 
genotypes (B). S1S2I, S3I, S5I, and AP41I indicate immunity genes for the 
associated S-type pyocin gene (A) and S1/I, S3/I, AP41/I, and S5/I indicate that 







































Spatial variability in pyocin genotypes 
To further understand whether the pyocin genotypes of our organisms 
differed across spatial scale, we compared the total number of pyocin genes or a 
subset of this, the killing genes, across the nine houses and two drain types.  We 
found that isolates from different houses varied with respect to the number of 
immunity genes, but not in regard to the number of killing genes or total number 
of pyocin genes. We found isolates from houses G, A, and H to encode the 
highest number of total pyocin genes with averages of 3.5 genes per isolate. 
These houses are followed by isolates from house F (3 genes per isolate), house 
E (2.5 genes per isolate), houses C and D (2 genes per isolate), and house B 
with an average of 1 pyocin gene per isolate. Additionally, we found that all 
isolates within the same drain have identical pyocin genotypes for all the houses. 
Furthermore, in four homes (B, C, D, and F), all isolates in both bathroom and 
kitchen sink drains carry identical pyocin genotypes. However, isolates collected 
from houses A, G, and H display differences in pyocin genotype across drains. A 
general mixed linear model using “house” as a variable showed no significant 
differences among all houses with respect to total pyocin gene content (p=0.076). 
Isolates from houses G, A, H were found to carry the highest number of 
pyocin killing genes with a mean of 3, 2,5, and 2.5 killing genes per isolate, 
respectively, while houses C-F were found to carry an average of 2 killing genes 
per isolate (Fig. 10B). House B was found to carry the lowest number of pyocin 
killing genes per isolate with an average of 1 killing gene per isolate. Similar to 
the total number of pyocin genes, “house” was not significant with respect to the 
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number of killing genes (Fig. 10B, p=0.48) 
Isolates from houses B, C, and D were not found to carry any known 
immunity genes, while isolates from house A, F, and H were found to encode the 
highest number of pyocin immunity genes with a mean number of 1 gene per 
isolate. In contrast, isolates from house E and G were found to carry an average 
of 0.5 immunity genes per isolate (Fig. 10C). Unlike the total number of pyocin 
genes or just the killing genes, houses were significantly different in the number 
of pyocin immunity genes (Fig. 10C, p=0.0018).  
Figure 10. Mean number of total pyocin genes (A), killing genes (B), and 
immunity genes (C) per isolate across the eight homes in this study. Mean 




















































Bathroom isolates encode more genes than kitchen isolates 
In previous studies, bathroom and kitchen sink drains were found to differ 
in the likelihood that each of these drain types were to yield P. aeruginosa [74]. 
Furthermore, in our previous study [17], we found slight differences in pyocin 
inhibition and susceptibility profiles between isolates collected from different drain 
types. We therefore hypothesized that isolates collected from different drain 
types would differ from one another in their pyocin gene content. We found that 
isolates collected from bathroom sink drains encode significantly more pyocin 
immunity genes and total number of pyocin genes compared to those collected 
from kitchen sink drains (p=0.0093 and p=0.02, respectively) (Fig. 11A and C). 
Isolates from bathroom sink drains also carry more genes for pyocin killing genes 
than those from kitchen sink drains (Fig. 11B), but these differences are not 
significant (p=0.181). Isolates from bathroom sink drains encode an average of 
roughly 2.5 killing genes, 0.6 immunity genes, and 3.2 total pyocin genes per 
isolate. Isolates from kitchen sink drains carry an average of 1.9 killing genes, 
0.19 immunity genes, and roughly 2.1 total pyocin genes per isolate. These 
results suggest that both drain type and house of origin appear to contribute to 
pyocin genotype selection.  Next, we sought to determine if the presence of 
genes or combination of genes correlates with these isolates ability to kill other P. 
aeruginosa isolates. 
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Figure 11. Mean number of total pyocin genes (A), killing genes (B), and 
immunity genes per isolate across bathroom and kitchen sink drains. Mean 
number of genes are estimated marginal means with 95% confidence intervals. 
*0.01 < p < 0.05; **0.001 < p < 0.01.
Relationship between pyocin genotype and the ability to kill other P. 
aeruginosa isolates 
We have previously reported on the interaction between these P. 

















































assess whether one type of pyocin is more potent than others, we calculated the 
likelihood of inhibition for strains containing S-, R-, and F-type pyocins.  As 
shown in Figure 12B, strains bearing genes encoding R-type pyocins are more 
likely to inhibit other strains.  However, this experiment may be biased as strains 
often bear two or more pyocin genes.  Because of this, all individual pyocin 
genotypes were then compared. To eliminate the role of immunity proteins in this 
analysis, all interactions in which indicator isolates carried genes encoding 
immunity proteins were excluded. Overall, pyocin killing gene combination 
significantly affected the outcome of inhibitory interactions (p<0.001). We found 
that isolates carrying only an R-type pyocin exhibited the highest predicted 
probability of inhibition with a probability of 0.65 (Fig. 13). This was followed by 
the genotypes S1-R, S3-R-F, and S2-R-F with predicted probabilities of 0.59, 
0.53, and 0.47, respectively. Pyocin killing gene genotypes with the lowest 
predicted probabilities of inhibition were S1-S5-R-F, S1-AP41-R, and S2-F 
(predicted probabilities of 0.4, 0.4, and 0.18, respectively). 
Finally, the roles of immunity proteins in P. aeruginosa interactions were 
examined.  We assessed whether the presence of an S-immunity gene in a strain 
protected that isolate from inhibition by a producer carrying an S1 or S2 killing 
gene.  The predicted probability of inhibition was significantly higher for isolates 
that were not found to carry the S1/S2 immunity gene when compared to those 
isolates that did carry the immunity gene (Fig. 14, p=0.035). 
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Figure 12. Predicted probability of inhibition when a producer isolate carries a 
gene for at least one S-type pyocin (A), an R-type pyocin (B), or an F-type pyocin 











































































Figure 13. Predicted probability of inhibition among different combinations of 
killing genes in the producer isolate and when there are no immunity genes 
present in the indicator isolate. Predicted probabilities of inhibition are estimated 
marginal means with 95% confidence intervals. Tukey’s test for multiple 




























Figure 14. Predicted probability of inhibition when an immunity gene is present 
or absent in the indicator isolate. Predicted probabilities are estimated marginal 
means with 95% confidence intervals. *0.01 < p < 0.05. 
Discussion 
Pyocin genotype diversity in environmental isolates 
We found that all 46 isolates in our collection encode genes for at least 
one type of pyocin. These results are consistent with the findings of other 
studies, particularly those of Olubukola et al. [135], who similarly found that all 24 
of the CF isolates in their collection encoded genes for least one type of pyocin, 
signifying the extremely high abundance of these narrow-spectrum antibiotics in 































types in our study varies slightly from previous findings. Similar to our results, 
Snopkova et al. [141] found some of the most commonly encoded pyocin genes 
to be that of R and S2, which were present in their strains at 67% and 67.4%, 
respectively, and were present in our strains at 63% and 43.5%. We found that 
all of our isolates carried genes for at least one talocin, while 81.4% carried 
genes for at least one S-type pyocin. Snopkova et al. [141] found S-type pyocins 
in a greater abundance at 93%, and talocins were found at a lower abundance of 
80%.  
Similarly, Ghoul et al. [88] found S-type pyocins present at a rate of 98% 
and Bakaal et al. [50] found these soluble pyocins present at a rate of 95%. Bara 
et al. [55] observed that over 50% of the isolates in their study lacked genes for 
S-type pyocins. The pyocin genotypes observed in our isolate collection vary 
from those of other studies as we appeared to have far less unique pyocins in 
comparison to that of Bara & Remold [55], who found the isolates in their study to 
encode 41 unique pyocin gene combinations across the 116 isolates used in 
their study, and Snopkova et al. [141], who observed 53 unique pyocin 
genotypes in the 135 isolates used in their study. We found only seven unique 
genotypes in the 46 isolates examined in our study.  
 The observation that our isolate collection differs from other studies in the 
prevalence of particular pyocin genes and overall diversity in pyocin genotype 
could exist because the origins of our strain collection are different from those of 
other studies. Studies done by Snopkova et al. [141], Ghoul et al. [88], and 
Bakaal et al. [50] involved the use of clinical strains derived from catheter 
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infections, lung infections in individuals with CF, or non-CF isolates derived from 
other human infections such as those in burns. The study done by Bara et al. 
[55], which included environmental and CF-associated isolates, determined that 
environmental isolates differed from those derived from individuals with CF in 
terms of both pyocin phenotype and genotype. As such, it is possible that the 
pyocin gene content differences between our study and others of could be the 
result of differences in the environment of isolation. Another potential source of 
variation could be in sampling bias. Our collection has isolates from nine houses. 
If more houses had been sampled, it is possible that more genotypes would have 
been detected. 
Environmental and clinical isolates may differ in pyocin gene content due 
to the potential role that pyocins play in mediating the outcome of competitive 
interactions during initial infection. If the presumption that initially infecting strains 
are environmental in nature is correct, the strains that are most likely to 
outcompete and remain in the host environment may be able to do so due to a 
competitive advantage provided by an abundance and diversity of pyocin genes. 
Alternatively, isolates carrying fewer pyocin genes may have a competitive 
advantage as they do not incur the cost of carrying and producing these 
antimicrobials. It could also be that pyocin genes are pleiotropically linked to 
other virulence factors that are important for initial colonization and persistence in 
the host environment. Snopkova et al. [141] found a number of strong positive 
and negative co-associations between pyocin genes and virulence genes, 
suggesting a relationship between pyocin gene content and the ability to cause 
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infection. For example, they found the presence of pyocin AP41 to have a strong 
positive association with overall antibiotic resistance; however, other studies 
have shown that the presence of the R/F pyocin gene cluster may increase 
susceptibility to fluoroquinolones due to induction of the lytic system [142]. If 
certain pyocin genes and virulence factors are pleiotropically linked, it could be 
that certain pyocin genes are passively selected for or against along with genes 
that play an important role in initial host colonization or persistence in the host 
environment. More work is needed in examining the functional role that pyocin 
production may play when isolates are initially colonizing the host environment 
and if these genes continue to play an important role in allowing an isolate to 
persist in the host environment or if these genes may only be passively selected 
for during host colonization and subsequent adaptation.  
Lastly, we found very distinct patterns in the S-type pyocin gene pairs in 
our isolates as pyocins S1, S3, S5, and AP41 are always encoded in isolates 
along with their cognate immunity protein. However, in our isolate collection, 
pyocin S2 is never accompanied by an immunity protein. The presence of so-
called “orphan” pyocin genes has been commonly identified across studies and 
encompasses both orphan immunity genes in which an immunity gene is found 
without its cognate killing gene and orphan killing genes in which killing genes 
are present without an immunity gene [55, 88] . Our findings of only orphan killing 
genes in pyocin S2 is difficult to interpret, as these immunity genes are presumed 
to protect a producing cell so that a producer can be immune to its own pyocin 
killing protein. There could be novel genes encoding immunity to the S2 pyocin 
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that have yet to be discovered.  Towards this, in our inhibition assays, we never 
observed self-on-self inhibition, meaning that no isolate was able to inhibit itself 
via pyocin production, which suggests that resistance to pyocins may be more 
complex than previously thought and mediated not only through the presence of 
immunity proteins, but potentially also through other mechanisms, perhaps 
related to cell surface receptors or secondary immunity genes. More work is 
needed to elucidate the mechanisms underlying the ability of the pyocin killing 
gene to exist singly without an immunity gene, perhaps due to alternative 
mechanisms of immunity.  
Spatial isolation contributes to patterns of pyocin gene content 
We examined differences in pyocin genotypes from isolates collected from 
different homes and found that the genomes of these isolates were most likely to 
differ in the number of pyocin immunity genes. The diversity in the number of 
pyocin-encoding genes among isolates collected from different houses as well as 
the limited diversity within drains and, to an extent, within homes is reasonable 
based on our phenotypic observations of these isolates in laboratory inhibition 
assays. We found a significant effect of house of the outcome of inhibitory 
interactions as well as differences in both inhibition and susceptibility profile 
among isolates from different houses [17]. Additionally, we found that isolates 
from different houses were most likely to inhibit one another, followed by isolates 
from different drains in the same house, and isolates from the same drain never 
inhibited one another. Taken together, these pyocin phenotypic and genotypic 
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observations confirm our conclusions from our previous study that historical 
processes such as dispersal limitations across houses and, in some cases, 
across drains within houses, contribute to the phenotypic patterns of pyocin 
diversity observed in our strain collection [17]. However, without more information 
on each of the houses in the sampling studying, we cannot rule out the potential 
for contemporary abiotic or biotic conditions to play a role in contributing to 
pyocin genotype or phenotype of the isolates in our study. Conditions such as 
inputs into the drains, amount of water flow, cleaning habits, and characteristics 
of the inhabitants of a home are contemporary processes that could impact the 
drain populations of P. aeruginosa. More information on the environment of 
isolation is needed to distinguish between the relative importance of historical 
processes and current conditions in shaping patterns of pyocin diversity. 
Current environmental conditions contribute to pyocin gene content 
We examined pyocin gene content from isolates collected from different 
drain types (bathroom and kitchen sink drains) and found that isolates derived 
from bathroom sink drains encoded significantly more pyocin killing and immunity 
genes when compared to those collected from kitchen sink drains. These results 
are interesting because, in our previous study, we observed that bathroom sink 
drain isolates were significantly less likely to inhibit kitchen sink drain isolates  
[17]. However, based on our findings in this study and others [55], the total 
number of pyocin genes does not appear to accurately predict the outcome of 
pyocin-mediated interactions in laboratory settings. We propose that this is due 
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to the extreme complexity of pyocin genetics as it involves not only killing and 
immunity genes, but also an intricate regulatory system as well as receptor 
variability that most certainly could account for a particular isolates likelihood of 
being killing by a particular pyocin [80]. Furthermore, it could be that the number 
of pyocin genes is not an important predictor in the outcome of inhibition, and 
instead, the particular killing genes an isolate is carrying may indicate whether or 
not it is more likely to inhibit when compared to other isolates.  
Additionally, these findings indicate that, even across homes, isolates 
collected from different sink drain types differ with respect to their pyocin 
genotype. These findings suggest that there are factors, either abiotic or biotic, 
contributing to differences in pyocin gene content in isolates collected from 
different sink drains. Analyses of bacterial community composition in bathroom 
and kitchen sink drains in our group have indicated that sink drain types differ 
from one another and kitchen sink drains appear to have overall higher bacterial 
diversity when compared to bathroom sink drains (A.A.M, unpublished data). It is 
possible that the biological differences in drain types could account for the 
differences observed in pyocin genotypes. If P. aeruginosa isolates face more 
diverse competitors within the kitchen sink drain environment, producing a higher 
number of pyocin genes may not provide a competitive benefit due to the costly 
nature of carrying and releasing these antimicrobials [80, 82]. Furthermore, as 
bacteriocins are primarily thought to mediate intraspecific interactions, pyocin 
production may not be beneficial if the bacterial community is highly diverse and 
composed of members of distant taxa. There could also be differences in abiotic 
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factors between drain types such as resource availability and frequency of use. 
More work would be needed in characterizing specific abiotic and biotic 
differences in drain types to elucidate the mechanisms driving differences in 
pyocin gene content observed among isolates collected from bathroom and 
kitchen sink drains.  
Isolates carrying only R-type pyocins are most likely to inhibit 
While several previous studies have focused on pyocin genotype diversity 
and overall abundance of pyocin genes in P. aeruginosa populations, few studies 
have investigated the extent to which different pyocin killing genes and 
combinations of killing genes contribute to the outcome of inhibitory interactions. 
We investigated the differences in the probability of inhibition for seven different 
pyocin killing gene genotypes in interactions in which the indicator isolates carry 
no immunity genes to S-type pyocins. We found producer isolates carrying genes 
encoding for an R-type pyocin to have the highest probability of inhibition, while 
isolates carrying genes for S2 and F-type pyocins to have the lowest likelihood of 
inhibition in our study (Fig. 13).  
Our finding that isolates carrying genes encoding for an R-type pyocin had 
the highest predicted probability of inhibition are reasonable in the context of a 
study done by Oluyombo et al. [135] in which R-type pyocins were found to play 
a significant role in the outcome of inhibitory interactions among CF isolates of P. 
aeruginosa; R-pyocin deletion mutants were observed to lose the capacity for 
inhibition when compared to their R-pyocin carrying counterparts. These 
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observations were consistent across both planktonic cultures and growth in a 
biofilm. Furthermore, when an R-sensitive strain was grown in a biofilm and 
treated with purified R-type pyocin, a significant decrease in the number of viable 
cells was observed. Similar conclusions have been drawn in other studies in 
which R-type pyocins appear to significantly contribute to inhibitory interactions in 
clinical isolates of P. aeruginosa [50, 143]. This could be due to the relative high 
potency of R-type pyocins when compared to other types of pyocins; it has been 
shown that a single molecule of an R-pyocin can kill a sensitive cell whereas 
100-200 F-pyocin molecules and as many as 300 S2 pyocin molecules are 
needed to inhibit a competitor [114, 144, 145]. Furthermore, induction of R-type 
pyocin genes can result in the production of 200 pyocin molecules per cell [146].  
Interestingly, however, when an R-type pyocin is present with other killing 
genes such as an S-type pyocin (S1, S5, AP41, S3) and an F-type pyocin, the 
predicted probability of killing decreases. These findings are somewhat 
counterintuitive as it might be logical that a higher number of pyocin killing genes 
would provide a producer with the ability to inhibit a higher number of isolates. 
One explanation of this observation could relate to differential gene expression of 
pyocin killing genes. Numerous studies have confirmed that all pyocin killing and 
immunity genes are regulated in the same RecA-mediated manner; however, it 
has not yet been investigated if pyocin genes will be differentially expressed 
when they are present in combination with one another compared to when they 
are present singly in a producing cell. It is possible that we observed the highest 
rate of inhibition in isolates that carry only an R-type pyocin gene because the 
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presence of a single killing gene allows for more expression whereas, if multiple 
killing genes are present, expression levels of each gene may be lower to allow 
for concurrent expression. 
Another explanation for differences observed between interactions in 
which R is present alone and found with other pyocin killing genes could be 
related to talocin subtypes as we did not sub-type the R or F pyocins in this study 
and it is well-known that different talocin subtypes (R1-R5; F1-F3) differ in their 
receptor specificity and, as a result, differ in their killing range. Furthermore, we 
do not know the specific components of LPS, the receptor for R- and F-type 
pyocins, for each of the isolates in this study. Consequently, the specifics of how 
particular pairs of producer and indicator isolates interact with one another 
regarding their talocins are unclear. We may lack sufficient information to 
understand the entirety of our data. 
Presence of an immunity gene provides protection 
We found that, overall, isolates carrying an S1S2 immunity gene have a 
significantly lower probability of being inhibited by isolates carrying S1 or S2 
pyocin killing genes. These results are logical as they indicate that the presence 
of a gene encoding for an S immunity protein protects an isolate that is the target 
of the corresponding S killing protein. Despite this finding, however, there are two 
interesting observations of note in these results. The first is that, although 
isolates with an immunity gene are less likely to be inhibited, there is still a 
probability of 0.15 that an isolate with a gene for an S1/S2 immunity protein will 
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be inhibited by an isolate carrying a gene for an S1 or S2 killing protein. It is 
possible that, in these cases, perhaps the S1/S2 immunity was not expressed or 
was not expressed at levels sufficient enough to provide protection for the 
indicator.  
It should be noted that, in our inhibition assay, pyocin expression was 
induced using a DNA damaging agent, mitomycin C, only in producer isolates, so 
it is possible that the indicator isolate was not expressing the immunity gene or is 
only expressing it at low levels that are not sufficient to evade inhibition by the 
producer. Studies have shown that S6 pyocin immunity genes have higher levels 
of basal expression than the S6 killing protein [89]; however, it is unclear if this 
phenomenon is also observed in other S-type pyocin genes such as the S1/S2 
immunity gene. Alternatively, isolates carrying a gene encoding for the S1/S2 
immunity protein may still be susceptible to inhibition by the producer isolate if 
the killing results from mechanisms other than S2 pyocin production. While our 
inhibition assay method allowed us to rule out contact-dependent inhibition (CDI), 
we could not rule out inhibition through other mechanisms such as 
bacteriophage, other secreted antimicrobials, or even other pyocin types that 
were not characterized in this study. The second result of note is that not all 
isolates lacking an immunity gene are susceptible to a producer carrying a gene 
for the S2 killing protein. These isolates may not be susceptible due to other 
immunity mechanisms such as receptor incompatibility. More research is 
warranted to investigate basal level expression of pyocin killing and immunity 






should be noted that isolates carrying S1 or S2 pyocin genes also carried genes 
for R- and/or F-type pyocins, which could impact the trends observed in our 
study, as an R- or F-type pyocin could be responsible for killing activity in 
addition to an S-type pyocin in these interactions. None of the isolates in our 
study were found to carry only one S-type killing gene. Given this limitation, we 
were unable to distinguish between inhibition due to talocins or S-type pyocins in 
our inhibition assays. Therefore, we are cautious with the conclusions in this 
portion of our study and more investigation is needed into the potential protection 
that an immunity protein may provide from an S-type pyocin. 
 
Conclusion 
 This study aimed to characterize patterns of diversity in pyocin gene 
content among household isolates and investigate potential ecological, 
evolutionary, and genetic drivers of these patterns. We found that isolates from 
different houses differ primarily with respect to the total number of immunity 
genes found in each isolate, but do not significantly differ in the total number of 
all pyocin genes, suggesting a weak relationship between historical events such 
as dispersal limitations and pyocin gene content. Isolates collected from 
bathroom sink drains encoded significantly more killing and immunity genes, 
indicating that the current conditions, either abiotic or biotic, may play an 
important role in shaping patterns of diversity in pyocin genetics. Finally, isolates 
with S-type immunity genes have a significantly lower probability of being 
inhibited by S-type killing proteins, and isolates producing only R-type pyocins 
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exhibit the highest likelihood of inhibition than all other killing gene combinations. 
Overall, it appears that both dispersal limitations and local adaptation to current 
environmental conditions contribute in some capacity to pyocin genotype. 
Additionally, particular pyocin genotypes are more adept at killing than others, 
and S-type immunity genes protect isolates from being killing; however, it is likely 
that alternative mechanisms of resistance also play a role in the outcomes of 
inhibition. Furthermore, the massive complexity of the pyocin genetic system 
does not allow us to completely understand the genetic and mechanistic 
processes that are responsible for the outcomes of inhibitory interactions.
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Table 4. S-type pyocin genes screened in all genomes and reference genomes 
used to retrieve gene sequences.  
pyocin gene function gene name/locus tag genome 




protein imm2 (PA1151) 
Pseudomonas aeruginosa PAO1 
(Reference) 
S1 killing protein A4W92_RS05830 Pseudomonas aeruginosa ATCC 278534† 
S3 killing protein pyoS3A (PA14_49520) 
Pseudomonas aeruginosa UCBPP-
PA14‡ 
S3 immunity protein pyoS3I (PA14_49510) Pseudomonas aeruginosa UCBPP-PA14 
S5 killing protein pyoS5 (PA0985) Pseudomonas aeruginosa PAO1 (Reference) 
S5 immunity protein PA0984 
Pseudomonas aeruginosa PAO1 
(Reference) 
AP41 killing protein PADK1_RS07240 Pseudomonas aeruginosa DK1 substr. NH57388A§ 
AP41 immunity protein PADK1_RS07235 
Pseudomonas aeruginosa 
DK1 substr. NH57388A  
*RefSeq Assembly Accesstion GCF_000006765.1
†RefSeq Assembly Accession GCF_001618925.1 
‡RefSeq Assembly Accession GCF_000014625.1 
§RefSeq Assembly Accession GCF_900069025.1
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Table 5. R- and F-type pyocin genes screened in all isolate genomes. 
pyocin gene function gene name/locus tag genome 
- anthranilate synthetase I trpE (PA0609) 





repressor prtR (PA0610) 





activator prtN (PA0610) 
Pseudomonas aeruginosa PAO1 
(Reference) 
- Repressor ptrB (PA0612) Pseudomonas aeruginosa PAO1 (Reference) 
- Hypothetical protein PA0613 Pseudomonas aeruginosa PAO1 (Reference) 
R and 
F Holin PA0614 
Pseudomonas aeruginosa PAO1 
(Reference) 
- Hypothetical protein PA0615 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail spike PA0616 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail baseplate PA0617 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail baseplate PA0618 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail formation PA0619 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail fiber PA0620 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail fiber PA0621 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail sheath PA0622 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail tube PA0623 Pseudomonas aeruginosa PAO1 (Reference) 
R Hypothetical protein PA0624 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail formation PA0625 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail formation PA0626 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail formation PA0627 Pseudomonas aeruginosa PAO1 (Reference) 
R Tail formation PA0628 Pseudomonas aeruginosa PAO1 (Reference) 
R and 
F Lytic enzyme PA0629 
Pseudomonas aeruginosa PAO1 
(Reference) 
F Tail protein PA0630 Pseudomonas aeruginosa PAO1 (Reference) 
F Tail formation PA0631 Pseudomonas aeruginosa PAO1 (Reference) 
F Tail formation PA0632 Pseudomonas aeruginosa PAO1 (Reference) 
F Tail protein PA0633 Pseudomonas aeruginosa PAO1 (Reference) 
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F Tail protein PA0636 Pseudomonas aeruginosa PAO1 (Reference) 
F Hypothetical protein PA0637 Pseudomonas aeruginosa PAO1 (Reference) 
F Tail protein PA0638 Pseudomonas aeruginosa PAO1 (Reference) 
F Tail protein PA0639 Pseudomonas aeruginosa PAO1 (Reference) 
F Hypothetical protein PA0640 Pseudomonas aeruginosa PAO1 (Reference) 
F Hypothetical protein PA0641 Pseudomonas aeruginosa PAO1 (Reference) 
F Hypothetical protein PA0642 Pseudomonas aeruginosa PAO1 (Reference) 
F Hypothetical protein PA0643 Pseudomonas aeruginosa PAO1 (Reference) 
F Hypothetical protein PA0644 Pseudomonas aeruginosa PAO1 (Reference) 
F Hypothetical protein PA0645 Pseudomonas aeruginosa PAO1 (Reference) 
F Hypothetical protein PA0646 Pseudomonas aeruginosa PAO1 (Reference) 
F Hypothetical protein PA0647 Pseudomonas aeruginosa PAO1 (Reference) 
F Hypothetical protein PA0648 Pseudomonas aeruginosa PAO1 (Reference) 
- anthranilate synthetase II trpG (PA0649) 
Pseudomonas aeruginosa PAO1 
(Reference) 
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Figure 8. Presence/absence of all genes in the R/F pyocin gene cluster for each 
isolate. Grey squares indicate that the gene is present in that particular isolate, 
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